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Abstract 
 
Low health literacy is one of the main barriers to medication adherence.  People with low 
literacy often have difficulty understanding health information and making appropriate 
health decisions. Currently, medication information is presented to populations with low 
health literacy in a way that is difficult to understand. On average, individuals with low 
health literacy can read at a fifth-grade level, while medication information tends to be 
presented in a manner targeted for individuals who can read at a tenth grade level. With 
current medication information too difficult to understand, low health literate populations 
are at a higher risk of misinterpreting prescription label instructions, dosage, duration, 
frequency, warning labels, written information and verbal pharmacist counseling. 
Therefore, pharmacists need to provide medication information that can be understood by 
individuals with low health literacy and is also adopted into a busy pharmacy practice. 
The objectives of this thesis included the following: 1) To systematically review the 
evidence on interventions for improving medication knowledge and adherence for low 
health literate populations, 2) To explore the major challenges low health literate adults 
face when trying to understand their medication therapy. 3) To design an innovative 
medication counseling tool that improves the medication knowledge of patients with low 
health literacy.  
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 Chapter 1.0: Health literacy introduction 
 
Health literacy, a patient’s ability to obtain, read and understand medication information 
to make appropriate health decisions, should be a major consideration for pharmacists. As 
the role of the pharmacist evolves from filling prescriptions and counseling to delivering 
patient-centered care, pharmacists need to be able to ensure patients can understand and 
self-monitor medication. People make choices about their medication on a daily basis. 
Approximately half of North Americans use at least one prescription medication and a 
startling 53% of seniors living in institutions and 13% living in communities take five or 
more medications.
1,2
 At home, the patient’s understanding of medication information is 
essential to ensure accurate medication regimens are followed.
3
 Therefore, good 
communication between pharmacists and patients is fundamental for the safe and 
effective use of medications.
1,2 
1.1. Health Literacy and Medication Information 
On average, individuals with low health literacy can read at a fifth-grade level, while 
medication information tends to be presented in a manner targeted for individuals who 
can read at a tenth grade level.
4
 With current medication information too difficult to 
understand, low health literate populations are at a higher risk of misinterpreting 
prescription label instructions, dosage, duration, frequency, warning labels, written 
information and verbal pharmacist counseling.
5
 Patients who struggle to understand 
medication information are more likely to be unable to self-manage their health and make 
appropriate health decisions.
6
 There is a clear gap between the levels of skill required to 
understand current medication information and the actual level of understanding among 
low health literate populations.  
2 
 
Health literacy is essential for individuals to confidently understand, act and 
communicate personal medical needs and maintain good health.
1 
Adequate health literacy 
allows people to self-manage their health and to apply health information on a daily 
basis.
6
 Health literacy differs from general literacy because it involves the simultaneous 
ability to read, understand health instructions and to communicate medical information.
7
 
1.2. Prevalence  of  Health Literacy 
In recent years, there has been an increasing interest in health literacy due to the large 
number of individuals with low health literacy.
5- 7 
In Canada, 60% of adult Canadians do 
not have the ability to obtain, understand and act on health information.
8
 In the United 
States, 35% of adults have difficulties understanding, interpreting and applying health 
information.
9
 Similarly, one third of older adults in England have problems 
understanding and comprehending basic health information.
10
 There is an increasing 
concern that low-income adults, ethnic/racial minorities and seniors in North American 
have the highest prevalence of low health literacy.
11
  
1.3. Health literacy Associated Health Outcomes 
Low health literacy is not only highly prevalent but also associated with poor health 
outcomes, higher hospitalization rates, higher risk of mortality, greater chance of 
medication errors and lower rates of treatment adherence.
5
 Additionally, a systematic 
review found low health literacy to be responsible for an additional 3 to 5% of total 
annual health-care costs.
12
 A study conducted by Schillinger et al. in 2002 explored the 
relationship between health literacy and health outcomes among patients with type 2 
diabetes.
13
 After controlling for socio-demographic characteristics, depressive symptoms, 
social support, treatment regimen and years with diabetes, lower health literacy scores 
3 
 
were independently correlated with poorer glycemic control, where people with low 
health literacy were twice as likely to have poor glycemic control (OR=2.33, p=0.02) 
compared to people with adequate health literacy scores.
13
  
1.4. Improving Health Literacy 
The World Health Organization (WHO) has identified health literacy as one of the main 
patient-related factors associated with non-adherence and argue that interventions 
targeted to improve adherence will positively affect the health of patients more than other 
interventions.
11, 14
 For this reason, the safety of patients with low health literacy is a 
primary goal and there is an immediate need to develop effective solutions to improve 
medication information for this population.
11, 14
  
1.5. Health Literacy Recommendations 
 
The health literacy expert panel of the Canadian Public Health Association 
(CPHA) envisions all Canadians as having the capacity and support to obtain and 
accurately use health information for the self-management of health.
15,16
 The expert panel 
recommended three goals for improving health literacy and attaining the health literacy 
vision: 1) to improve health literacy skills in Canada, 2) to reduce health inequalities 
found in seniors, ethnic/racial minorities, and low-income families by developing health 
literacy skills, and  3) to provide health information and services for people at all levels 
of health literacy.
16
 Both the CPHA and WHO indicate the importance of health literacy 
and recommend developing health information  that meet the needs of all population 
groups.
16, 17
 
 
4 
 
1.6. Thesis Objectives & Hypothesis  
 
Given the need for improved medication information, there is a clear gap between 
the level of ability required to understand current medication information and the level of 
understanding that is present among the low health literate population. The objectives of 
this thesis included the following: 
 
1) To systematically review the evidence on interventions for improving 
medication knowledge and adherence for low health literate populations; 
 
2) To explore the major challenges low health literate adults face when trying 
to understand their medication therapy; 
 
3) To design an innovative medication counseling tool that improves the     
medication knowledge of patients with low health literacy. 
1.7. Conclusions  
 
The notion of communicating information in a “one size fits all” approach does 
not consider individuals who have different learning needs, abilities and preferences, 
especially when that one size is meant for patients with adequate health literacy levels.
14 
There is a need for novel methods for conveying medication information that is 
understandable and usable for all individuals.  
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Chapter 2.0: A systematic review of interventions to improve 
medication information for low health literate populations  
 
2.1. Introduction 
 
Health literacy has gained considerable attention in recent years for improving 
medication infromation.
1-17
 To our knowledge, there are no systematic reviews that have 
explored interventions targeted to improving medication information for low health 
literate populations. Previous systematic reviews on health literacy interventions have 
explored the positive association with health literacy and diabetes knowledge 
18
, the 
effectiveness of interventions to improve health literacy 
19
 and the association between 
low health literacy and poor health outcomes.
20
 Therefore, the primary objective of this 
paper was to systematically review the evidence on interventions for improving 
medication knowledge and adherence for low health literate populations. Secondary 
objectives were to identify different categories of medication information intervention, to 
identify strategies used by effective interventions and to review the effect of interventions 
on clinical outcomes and user experience.  
2.2. Material and Methods 
 
In preparing this review, the methods outlined in the Cochrane Handbook for Systematic 
Reviews of Interventions Version 5.1.0, and the 27-item Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses checklist (PRISMA) was followed, to ensure 
transparent and complete reporting.
21, 22 
 
2.2.1. Criteria for considering studies for this review 
 
8 
 
2.2.1.1. Types of Intervention Studies  
Interventions focused on using domains of health literacy to improve medication 
knowledge and/or adherence was included. Studies were included if they explicitly stated 
they included low health literate populations, included outcome measures for knowledge 
and/or adherence, focused on medication information, were written in English and were 
available in full text. When full text articles were not available, one author (HW) 
contacted the researcher and requested full text access. All study designs, including 
randomized controlled trials (RCT), non-randomized controlled trials (NRCT) and 
uncontrolled trials (UCT) were included.  In order to define the health literacy of 
medication information for the inclusion criteria, four domains of health literacy were 
adapted, as described by the Institute of Medicine expert panel to medication 
information.
23
  These included: 
1) Cultural and conceptual knowledge: the understanding medication information  
2) Oral literacy: the ability to listen to and communicate medication information  
3) Print literacy: the ability to read and understand written medication information 
4) Numeracy: the ability to understand numbers associated with the dosage, directions, 
quantity of medications and refills. 
 
Full text papers were excluded if there was no clear mention of an intervention being 
studied, if the intervention had no focus on any of the domains of health literacy, if there 
was no measure of medication knowledge or adherence and if the authors did not specify 
the inclusion of patients with low health literacy.  
2.2.1.2. Types of Participants 
 
9 
 
Currently, there is no gold standard for identifying patients with low health literacy. 
Studies were included if they identified at least one of the following measures of low 
health literacy: written assessments, verbal assessments and demographic characteristics 
was included. Written assessments of health literacy are the most common method of 
determining health literacy levels.
24  
Written assessments consist of a set of questions for 
which an individual must provide a written answer within a specified time restriction. 
Examples include the Rapid Estimate of Adult Literacy in Medicine  (REALM) 
24
, the 
Test of Functional Health Literacy in Adults (TOFHLA) 
24 
, the Short-Test of Functional 
Health Literacy in Adults (STOFHLA) 
24
, Peabody Individual Achievement Test (PIAT) 
and the Newest Vital Sign (NVS).
25
 Verbal assessments are a quick method of 
determining health literacy level and typically consist of oral questions that are answered 
using a 5-point Likert scale to identify a patient’s self-assessed health literacy level.26, 27 
The demographic characteristics most associated with low health literacy include 
belonging to an ethnic/racial minority, older age, low household income and low 
education.
11
 
2.2.2 Types of Outcome Measures 
 
2.2.2.1. Primary Outcome Measure 
 
The primary outcome measures were the improvement in medication knowledge and the 
improvement in medication adherence.  Medication knowledge was determined through 
verbal or written questionnaires and surveys. Pill counts, prescription records, patient 
self-report and electronic devices such as smart pill vials were used to determine 
adherence.  
10 
 
2.2.2.2. Secondary Outcome Measures 
 
The secondary outcome measures included clinical outcomes measures, user experience 
and preference. Clinical outcome measures were included to provide empirical evidence 
for effective interventions. Examples of clinical outcome measures include blood 
pressure, cholesterol, hemoglobin A1c, asthma control, weight loss, Body Mass Index 
(BMI), hospitalization and death. User experience and user preference provide 
information on what aspects of the intervention the user likes, wants and needs and 
include satisfaction, practicality, usage and acceptability of the intervention.  
2.2.2.3. Search Methods For Identification of Studies 
 
A health librarian assisted in identifying existing literature on health literacy and 
medication information for low health literacy populations. PubMed, Embase, 
International Pharmaceutical Abstracts (IPA), Web of Science, Cochrane Library, 
CINAHL, PsycINFO, and Scopus was searched from the start of each database to studies 
published before March 30, 2015. For the search strategy, the combination of the words 
“medication adherence,” “health literacy,” “medication information,” including the 
corresponding MeSH terms. The reference lists of the literature found in the database 
search were hand searched for any remaining articles. To identify grey literature, the 
Google search engine was searched using the same methods and terms described above. 
An example of the search strategy includes the following: 
(Medication adherence OR medication non adherence OR medication non-adherence OR 
medication compliance OR drug adherence OR drug non adherence OR drug non-
adherence OR drug compliance OR patient adherence OR patient non adherence OR 
patient non-adherence OR patient compliance OR medication non compliance OR 
medication non adherence OR drug non compliance OR drug non-compliance OR patient 
non compliance) AND (Health literacy OR health literate OR medical literacy OR 
medication literacy OR low health literacy OR low health literate OR literacy OR 
illiterate OR functional literacy OR functional health literacy OR adult literacy OR 
patient literacy OR drug literacy OR patient understanding OR patient knowledge) AND 
11 
 
(medication information OR prescription information OR drug information OR verbal 
information OR oral information OR written information OR patient information OR 
health education OR health knowledge OR pharmacy counseling OR communication OR 
health information OR medical information OR pharmacy information OR pharmacy OR 
prescription OR medication OR drug OR pharmacist-patient OR pharmacist patient OR 
patient-pharmacist OR patient pharmacist) 
 
2.2.3. Data Collection and Analysis 
 
2.2.3.1. Selection of Studies 
 
One author (HW) performed the search and combined all database titles into RefWorks 
2.0 and removed all duplicates. All database titles were transferred into Mendeley, where 
three authors (HW, KG, ZH) reviewed 10 randomly selected titles as a group, to clarify 
any uncertainty with the inclusion/exclusion criteria. After all reviewers were certain with 
the inclusion/exclusion criteria, all three reviewers independently screened titles, 
abstracts and full text papers. The authors were not blind to any of the journal articles’ 
information. Conflicts in evaluating articles for inclusion were resolved through a 
discussion between reviewers.   
2.2.4. Data Extraction and Management 
  
 The following data were extracted from each included article: author, publication year, 
country, study design (type randomization, sample size), objective, subjects (gender, age, 
ethnicity/race, income, health literacy, education), health literacy assessment tool, 
intervention characteristics (type, passive or active, technology based) outcome measure, 
outcome effectiveness.  
 
Using thematic analysis, all studies interventions were coded with NVivo 10 (QSR 
International Pty Ltd) by first identifying the intervention, comparing the types of 
12 
 
intervention and categorizing interventions into themes. A similar method was used to 
identify strategies used to create an effective intervention. To reduce the risk of bias, data 
extraction was confirmed by a second reviewer. 
2.2.4.1. Assessment of Risk of Bias in Included Studies  
 
Bias was assessed using the Cochrane Handbook for Systematic Reviews interventions.
28 
In total, five strategies to reduce bias were assessed including random sequence 
generation/allocation concealment (selection bias), blinding of participants and personnel 
(performance bias), blinding of outcome assessment (detection bias), incomplete outcome 
data (attrition bias) and selection reporting (reporting bias).
28
 Review Manager (RevMan 
5.2) was used to determine the risk of bias, where each study was assigned to be either 
low or high risk of bias based on the above characteristics.  
2.3. Results 
2.3.1. Characteristics of reviewed studies  
The review identified 1553 titles, 1009 abstracts, 160 full text articles and included 47 
full text articles for review (Figure 2.1). The inter-rater agreement for included abstracts 
was 97.2% and for included full text articles was 98.5%. The 47 intervention studies 
included 27 randomized controlled trials, 8 non-randomized controlled trials and 12 
uncontrolled trials (Table 2.1). Of the 47 included studies, 70.2% (33/47) were published 
in the United States and 87.2% (41/47) were published between 2005 and 2014. A variety 
of different tools were used to assess health literacy. After assessing for risk of bias, 
27/47 studies were at low risk, 8/47 studies were of moderate risk and 12/47 studies were 
at risk of bias. 
13 
 
2.3.1.1. Health literacy assessment and demographic characteristics 
To measure health literacy, 51% (24/47) of studies used the REALM or 
STOFHLA/TOFHL. Other verbal assessments, which include the newest vital sign 
(NVS), readability assessments, Peabody Individual Achievement Test (PIAT-R) and 
three-item health literacy-screening test accounted for 12.7% (6/47) of studies. A total of 
36.2% (17/47) of included studies relied on the four main demographic characteristics of 
low health literacy (older age, ethnic minority, lower income, lower education) to identify 
low health literacy. As outlined in Table 2.2, all studies used an objective measure of 
health literacy also included at least 2 of the higher risk populations.  Twenty-eight 
studies reported on at least two of the four characteristics 
29, 34, 37-39, 40, 41, 43-45, 47, 49, 50-53, 57, 
58, 60-63, 65, 66, 68, 69, 71, 75
, 9 reported on at three of the four characteristic. 
34, 37- 40, 52, 61, 71, 75
, 
and 3 reported on all four demographic characteristics 
45, 47, 65
.  Furthermore, 28 of the 30 
studies did not provide detailed information and therefore may have been missing data in 
the results. 
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Figure 2.1: Systematic Review Flow Chart  
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2.3.2. Categories of interventions  
 
Figure 2.2: Categories of medication information interventions 
 
Type of intervention  Description  Examples  
1. Written 
Information 
Information expressed in writing  Patient information 
leaflet 
2. Visual 
information 
Information expressed with picture 
elements 
Pictograms 
3. Audible/verbal 
information 
Information that expressed in 
spoken words 
Counseling  
4. Label information  Information expressed on 
medication bottle  
Simplified medication 
instructions 
5. Reminder systems Serves to remind patients about 
important medication information  
Automated telephone 
reminder 
6. Educational 
programs/service 
A plan or schedule of action for a 
specific period of time  
Pharmacy based 
program 
 
 
2.3.2.1. Effect of interventions  
 
Overall, of the 47 studies included in the review, 37 interventions 
29-32, 34, 35, 36-40, 42, 43, 45-48, 
50-52, 54, 55, 56-60, 62, 63-69, 71, 73, 74
 provided information on knowledge and 26 interventions 
provided information on adherence. 
30, 31, 33, 34, 37, 40, 41, 43, 44, 45, 48, 49, 53, 54, 55, 57, 61, 63-65, 68, 70-
73, 75
 There was a significant improvement in knowledge in 27 studies, 
30-32, 34, 35, 36-39, 43, 45, 
48, 52, 55, 58, 59, 62-71, 73, 74. 
and a significant improvement in adherence in 19 studies. 
30, 33, 34, 
41, 45, 48, 49, 54, 55, 57, 61, 63-65, 68, 70-73, 75 
Six different types of medication information interventions were identified. The most 
common type of intervention was written information, followed by visual, verbal, 
educational programs/services, reminder systems and medication label information. 
Interventions were able to fall into multiple categories because many include 
multidimensional strategies such as the combination of audible, visual and written 
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information. Including all categories applicable to the intervention provided a better 
description of the intervention.  
2.3.2.2. Written information  
 
 
The 41 intervention studies of written medication information included patient-centered 
prescription instructions, culturally tailored information, worksheets, brochures, leaflets, 
booklets, personalized feedback reports, illustrated medication schedules, pictograms, 
animated computerized text and graphics, educational board games, text messages, and 
information through videos, websites and software programs. Of the 31 studies that 
provided outcome data on patient knowledge 
29-32, 34, 35, 37, 38, 39, 40, 42, 43, 45-48, 50-52, 54, 55, 56, 58, 
59, 62, 64-67, 69, 71
, 19 had a statistically significant improvement.
30-32, 34, 35, 38, 39, 43, 45, 48, 52, 55, 
56, 58, 59, 62-67, 69, 71  
Of the 22 studies that provided outcome data on adherence 
30, 31, 33-35, 37, 
40-42, 44, 45, 48, 49, 53, 54, 55, 61, 64, 65, 70-72, 75
, 15 studies showed a statistically significant 
improvement on adherence.
30, 33, 34, 41, 45, 48, 49, 54, 55, 61, 64, 65, 71, 72, 75 
2.3.2.3 .Visual information  
The 36 studies categorized as visual interventions included pictograms, color coded 
medication bottles, symbols label systems, illustrated medication schedules, culturally 
tailored visual aid, pamphlets, leaflets, animated audio booklets, educational videos, 
computerized programs and websites with graphics, animations and videos.  Of the 27 
studies that provided information on knowledge 
31, 32, 34-36, 39, 40, 42, 43, 45, 47, 48, 50, 51, 52, 55, 58, 
59, 62-66, 68, 71, 74
, 21 had a statistically significant improvement. 
31, 32, 34-36, 39, 43, 45, 48, 52, 55, 58, 
59, 62-66, 68, 71, 74
 Of the 22 studies provided information on adherence 
31, 33, 34, 37, 40-42, 45, 48, 49, 
53, 55, 57, 61, 63, 64, 65, 68, 70, 71, 72, 75
, 16 had a statistically significant improvement.
33, 34, 41, 45, 48, 
49, 55, 57, 61, 63, 64, 65, 68, 71, 72, 75
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2.3.2.4. Verbal information 
 
The 36 studies of audible information included health coaching, outpatient consultation 
services, audio booklets, interactive voice response calls (IVR), culturally and patient-
centered tailored videos, websites, multimedia educational programs and pharmacy 
counseling through standard counseling, medication reviews, phone counseling, 
personalized educational programs, and teach-back method. Of the 27 studies that 
provided information on knowledge improvement 
29-32, 34, 35, 39, 42, 43, 45, 47, 48, 52, 54, 55, 56, 59, 60, 
62-65, 67, 69, 71, 73, 74
, 22 studies had a statistically significant improvement.
30-32, 34, 35, 39, 43, 45, 
48, 52, 55, 56, 59, 62-65, 67, 69, 71, 73, 74 
Of the 21 studies that provided data on adherence 
30, 31, 34, 41, 
42, 45, 48, 49, 52-55, 57, 61, 63-65, 70-73, 75
, 17 studies had a significant improvement.
30, 34, 41, 45, 48, 49, 
54, 55, 57, 61, 63, 64, 65, 71-73, 75 
2.3.2.5. Label/ medication bottle  
 
The 6 studies categorized as prescription labels or medication bottles included medication 
bottle colors, label systems, prescription label instructions, pictograms, patient centered 
instructions and prescription label design. Of the 5 studies that assessed knowledge 
36, 
38,40, 56, 66
, 4 studies had a statistically significant improvement.
36, 38, 56, 66
 Of the 2 studies 
that provide data on adherence 
40, 61
, 1 study had a statistically significant improvement.
61
  
 
2.3.2.6. Reminder systems 
 
The 15 studies categorized as medication reminder systems included interactive voice 
response (IVR) calls, automated telephone reminder system, text messages, electronic 
blister pack, personalized medication schedule, medication adherence action plan, and 
medication technology. Of the 8 studies that assessed knowledge 
37, 39, 45, 48, 51, 52, 56, 59
, 6 
studies had a statistically significant.
39, 45, 48, 52, 56, 59
 Similarly, of the 10 studies that 
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provided information on adherence 
33, 37, 44, 45, 48, 53, 57, 72, 75
, 7 studies reported a 
statistically significant improvement.
33, 45, 48, 49, 57, 72, 75
 
2.3.2.7. Educational programs/services  
 
The 17 intervention studies classified as educational programs and services included, in 
person and Internet based self-management program, pharmacist initiated education 
intervention, personalized and multimedia educational programs, nurse delivered home 
visits and outpatient consultation services.  Of the 17 studies, 11 provided data on 
knowledge 
31, 39, 42, 48, 52, 54, 55, 62, 63, 71, 73
, of which 9 had a statistically significant 
improvement.
31, 39, 48, 52, 55, 62, 63, 71, 73
 Of the 14 studies that provided data on adherence 
31, 
33, 41, 48, 49, 54, 55, 57, 63, 70-74
, 12 studies reported a statistically significant improvement.
33, 41, 
48, 49, 54, 55, 57, 63, 71-74
 
2.3.3. Other intervention characteristics  
 
2.3.3.1. Active versus passive interventions  
 
Active interventions were defined as strategies that attempt to change a behavior or 
thinking of an individual through patient involvement. Passive interventions were defined 
as strategies where a patient is not required to participate or respond to the intervention. 
An example of an active intervention is an educational program and an example of a 
passive intervention is a set of simplified medication instructions.  
2.3.3.2. Active interventions 
 
Of the 21 active interventions studies that reported data on knowledge 
31, 32, 34, 35, 39, 42, 43, 
45, 48, 52, 54, 55, 60, 62, 63, 64, 65, 67, 69, 71, 73
, 17 had a statistically significant improvement.
31, 32, 34, 
35, 39, 43, 45, 52, 54, 55, 62-65, 67, 69, 71, 73 
Of the 21 studies that provided data on adherence 
31, 33, 34, 
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41, 42, 44, 45, 49, 53-55, 57, 61, 63-65, 70-73, 75
, 16 studies had a statistically significant 
improvement.
33, 34, 41 45, 49, 54, 55, 57, 61, 63-65, 71-73, 75
  
 2.3.3.3. Passive interventions  
 
Of the 15 passive intervention studies that included information on knowledge 
29, 30, 36-38, 
40, 46, 47, 50, 51, 56, 58, 59, 65, 74
, 8 studies had a significant improvement.
30, 36, 38, 56, 58, 59, 65, 74
 Of 
the 5 passive intervention studies that reported information on adherence 
30, 37, 40, 65, 70
, 2 
studies had a significant improvement.
30, 65
 
2.3.3.4. Language 
 
Four studies provided bilingual information for individuals who speak English as a 
second language through a variety of interventions that included a website, audio booklet, 
health coach and bilingual health care professional.
41, 43, 60, 68
 In all four studies 
information was translated into Spanish 
41, 43, 60, 68
 and in one of these studies also 
included a second translation into Cantonese.
68
 Of the three language studies that 
provided data on knowledge, two showed a significant improvement.
43, 68
 Of the two 
studies that included adherence, all two studies demonstrated a statistically significant 
improvement.
41, 68 
 2.3.3.5. Innovative technology  
Of the 47 studies in the review, 17 studies examined a digital technology in the 
intervention, which included telemonitoring devices, electronic blister packs with Near 
Field Communication (NFC) chip, handheld reminders, medication watch alarms and 
personalized medication schedule digital videos, multimedia education programs and 
audio booklets.
31, 33, 34, 41, 42, 43, 44, 49, 62, 65, 68, 69, 70, 72, 74, 75
 Newer digital interventions 
focused on the portability and accessibility often seen with mobile technology.
33
 For 
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example, one study examined the use of mobile technology with the combination of an 
NFC chip on a electronic blister pack, where patients were reminded to take their 
medication through a text message if the medication was not taken out of the blister 
pack.
33
  Additionally, audio booklets and personal digital assistant videos were highly 
desired by patients because they believed audible and visual information made the 
content more clear and assisted in recalling medication information.
33, 34
 Furthermore, a 
touch screen Personal Education Program found participants appreciated and were highly 
satisfied with animated and graphical information and found the program simple to 
use.
62,69
 
2.3.4. Strategies of effective interventions  
 
After thematic coding, 4 strategies were categorized as effective and patient-preferred 
interventions:  
1) Additional aids to enforce written information; 
2) Personalized information;  
3)  Ease of Navigation, and; 
4)  Accessibility. 
2.3.4.1. Additional aid to enforce written information 
 
Interventions that included additional sources of information, such as graphics, 
pictograms, icons, animations and verbal counseling in combination with written 
information were categorized as effective strategies for a health literacy intervention.
30, 39, 
41, 48, 49, 52, 64-67, 74
 A study conducted by Sahm et al. found the combination of written 
medication instructions with a graphical aid assisted in the accurate understanding of 
instructions.
66
 Visual aids provide an illustrated representation of medication information 
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and help individuals gain interest in information. Among the low health literate 
populations, written information with the combination of verbal communication or 
narration helped patient understanding.
43, 54, 55
 Savas et al. found that the combination of 
written and verbal information was significantly more effective than either strategy alone 
(p<0.0001).
67
 The participants strongly believed that the combination of engaging 
information and pictograms improved their knowledge of their medications.
34,
 
50, 52 
2.3.4.2.. Personalized information 
 
Individually tailored information is also an effective strategy.
39, 42, 48, 52, 54
 Tailored 
information ensures the needs of an individual are met, and that all material given is 
applicable. Lefante et al. found that medication reviews are an effective intervention 
provided they last an average of 30-minutes, are delivered through a one-on-one patient-
to-pharmacist interaction and are focused on helping patients understand their 
medications.
54 
 
2.3.4.2. Ease of Navigation  
 
The ability to easily navigate through information was categorized as a strategy for 
successful interventions. Formats that improve navigation include bullets, subheadings, 
icons, bolding, underlining, larger font size and shorter words.
29, 43, 53, 58, 62, 65, 66 
 Aker et 
al. developed an improved format of written patient information with the use of icons, 
subheadings, bolding, underlining and larger font size and found the navigation time 
decreased from 59 seconds with the standard material to 22-23 seconds for the improved 
material.
29
 Additionally, the Personal Education Program was an excellent example of 
simple navigation.
62 
The program provided users with an interactive touch-screen 
computer program and allowed users to have full control over what information they 
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would like to access by simply touching clearly labeled information.
62  
The Personal 
Education Program was used to teach older adults from senior programs about drug 
interactions with over-the-counter medications and significantly improved knowledge 
and participant satisfaction.
62
  
2.3.4.3. Accessibility 
 
Interventions that provided participants with information that they can have access to 
when needed was categorized as a strategy for an effective intervention.
32, 36, 51, 55, 72
 For 
example, Kripalani et al. developed illustrated medication schedule called a “pill card” 
that participants were given to take home and refer to when needed.
51
 Participants would 
carry the information in their purse or wallet and post it on the refrigerator.
51 
Additionally, having access to information at home also improved patient knowledge 
scores (p<0.001) better than information only received through counseling and visual 
aids.
32
  Automated telephone reminder systems were also effective and beneficial to help 
patients remember to refill their medications and provided patients with the option of 
refilling medication in advance to avoid long wait times in the pharmacy.
52,72
 
2.3.5. Clinical outcome measure 
 
Clinical outcome measures were provided by 9 out of 47 intervention studies and 
included blood pressure, cholesterol, hemoglobin A1c, asthma control, body mass index 
(BMI), hospitalization and death.
33, 39, 41, 42, 60, 61, 62, 72, 75
 Of the nine studies, six reported 
an improvement in clinical outcomes.
33, 39, 42, 60, 61, 75
 Brath et al. found that an electronic 
blister pack improved blood pressure and total cholesterol (p<0.02).
33  
Neafsey et al. 
found that a four-visit personal education program improved blood pressure for 82% of 
participants.
62
 A health coaching intervention had a 0.9% decrease in HbA1c% 
60
, while a 
23 
 
videotape education program increased weight loss without a significant change in 
hemoglobin A1c.
59
 Goeman et al found that a face-to-face education intervention for 
asthma improved asthma control (p<0.02) in a 2-month period and had a higher level of 
improvement over a 12-month period (p<0.001).
42
 In a 12-month randomized control trial 
of a primary care based self-management heart failure program, there were 42 fewer 
hospitalizations and one less death compared to usual care.
39
  Similarly, another 12-
month randomized control trial of a pharmacy-based program for patients with heart 
failure found a 19.5% reduction in emergency visits in the treatment group compared to 
usual care.
61
 
2.4. Discussion   
 
The present review was designed to determine the evidence on interventions for 
improving medication knowledge and adherence in low health literate populations.  
Overall, of the 47 studies included, 37 studies assessed knowledge and 26 assessed 
adherence. In total, 27 of the 37 studies assessing knowledge and 19 of the 26 studies 
assessing adherence found that the interventions had a statistically significant effect. This 
review demonstrates that interventions targeting low health literate population improve 
medication knowledge and adherence. Furthermore, the reviewed studies also show that 
interventions targeting low health literate populations benefit populations with moderate 
and adequate health literacy.  
 
After thematic analysis, the interventions fell into six categories of medication 
information: written information, verbal information, label information, reminder 
systems, and educational program/services. There are variety of different types of 
initiatives focused on improving patient knowledge and adherence. Written information 
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was the most commonly used intervention and may be explained by the fact that current 
pharmacy practice legally requires pharmacies to provide patients with written 
medication information.  
 
The results of this study also identified four strategies that were both effective and 
strongly preferred by patients, including additional aids to enforce written information, 
personalized information, ease of navigation and accessibility. People with low health 
literacy face challenges with interpreting, accessing and exchanging health information in 
consultation with healthcare providers.
1
 The most effective interventions are tailored 
interventions that tackle barriers to health literacy. Individuals with low health literacy 
often feel social stigma because of their difficulties understanding medication 
information due to possible barriers such as language, culture, accessibility and disability. 
Low health literate individuals may also feel like a burden to the health system and may 
be too ashamed to seek clarification from the pharmacist. Therefore creating information 
that addresses the barriers low health literate patient face may support individual self-
efficacy in these populations.   
 
In the review four studies translated medication information to remove any language 
barriers for patient.
41, 43, 60, 68
 However, translating medication information is not always 
practical or feasible. Challenges to translating information include finding equivalent 
terms in the translated language, translating information to a similar reading level, 
accounting for the numerous dialects and regional differences, and accounting for 
changes with label spacing and formatting.
5
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Medication adherence is a complex issue and education alone is not sufficient for positive 
long-term effects.
7
 One of the main challenges is that physicians and pharmacists have 
difficulty identifying people who have low literacy.
12
 While patients with low literacy are 
more likely to have difficulty reading medication bottles, and an estimated 50% of 
patients feel ashamed, do not seek assistance and often will not even inform their own 
family.
45, 46
 It is an alarming notion that many people face challenges with their health 
information in secret and that this secrecy can negatively impact their health. 
 
To improve the negative effects low health literacy imposes on medication adherence, a 
“shame free” and “blame free” environment must be established, where standard 
guidelines for obtaining information is provided to all individuals equally.
47
 Patient 
counseling alone is not sufficient for improving medication adherence because patients 
recall only half of what was discussed.
46
 Additional tools other than the traditional 
information provided by the pharmacist should be provided to patients to further aid their 
understanding of their medications. Given that 60% of the US population speaks English 
as a second language, an urgent intervention to improve medication information is 
needed to obtain the desired change in medication adherence.
12
 Formal and intensive 
education programs, such as diabetes self-management education have been shown to 
improve medication adherence, but unfortunately program space and accessibility are a 
barrier to many patients.
47
 
2.4.2. Limitations 
One of the main challenges of a review of this nature is that the interventions are 
heterogeneous. The interventions included had a variety of different methods used to 
determine knowledge and adherence, which added to the heterogeneity of the review. 
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Currently, there is no gold standards for determining health literacy levels. Also, while 
the scope of the review was on health literacy interventions for adherence and 
knowledge, other outcomes such as medication errors were outside the scope of this 
review. Furthermore, 12 of the 47 studies identified were found to be at high risk of bias 
because the studies lacked the presence of a control group or follow-up.  Additionally, 
there is no current standardized assessment for health literacy, but in this review the 
inclusion of a variety of different health literacy assessments was included to account for 
the variability. 
2.5. Conclusions  
Interventions designed to support low health literate populations can improve patients’ 
medication knowledge and adherence. The most common interventions are written 
interventions but other effective strategies include visual information, verbal information, 
specialized labels, reminder systems and education programs. The most effective 
interventions include additional aids that enforce written information, information that is 
personalized, information that is easy to navigate and tools that can be accessed when 
needed. 
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Table 2.1: List of studies included in systematic review 
Author 
 
Year Country Study 
design 
Setting Sample 
size 
Objective 
Aker et al.  29 2013 USA NRCT Research setting 105 To obtain consumer preferences to develop patient-friendly medication information. 
 
Al-Saffar et al. 30 2005 Kuwait RCT Hospital 278 To assess the acceptability and effectiveness of two educational initiatives on patterns of 
antidepressant medication use in Kuwait. 
 
Boyne et al. 31 2014 UK RCT Outpatient clinic 382 The aim of this prospective randomized multicentre telemonitoring study is to analyze the effects of 
telemonitoring on disease specific knowledge, self-efficacy, self-care and adherence. 
Braich et al. 32 2011 Canada RCT Across India 225 To examine the effectiveness of pictograms in educating low literacy patients to improve adherence 
to postoperative cataract regimens. 
 
Brath et al. 33 2013 Europe RCT N/A 53 To evaluate a mobile health (mHealth) based remote medication adherence measurement system 
(mAMS) in elderly patients with increased cardiovascular risk treated for diabetes, high cholesterol 
and hypertension. 
Brock and Smith 
34 
2007 UK UCT Outpatient clinic 51 To evaluate the effects of using an audiovisual animation displayed on a personal digital assistant 
(PDA) for patient education in a clinical setting. 
 
Burghardt,et al. 
35 
2013 USA NRCT Urban community pharmacy 185 To determine if the use of educational board games could impact community pharmacy patron 
intentions to seek pharmacist advice in an urban, minority, and economically- disadvantaged 
population. 
 
Cardarelli et al. 36 2011 USA NRCT Primary care clinics 100 To evaluate and refine an color-specific symbols system added to medication bottles and to evaluate 
the effectiveness with patients 65 years of age or older in identifying their medication. 
 
Cordasco et al. 37 2009 USA RCT Hospital discharge 210 To developed and evaluate a low-literacy medication education tool. 
 
Davis et al.  38 2008 USA UCT Hospital clinic 359 To describe dose and frequency of use for prescribed drugs could improve comprehension, 
especially among patients with limited literacy. 
Dewalt et al. 39 2006 USA RCT Hospital 123 To compare the effectiveness of a self-management program designed for patients with low literacy 
versus usual care in reducing hospitalizations and improve heart failure-related quality of life. 
Dowse and 
Ehlers 40 
2005 South 
Africa 
NRCT Hospital discharge 87 To determine the influence of medicine labels incorporating pictograms on the understanding of 
instructions and on adherence. 
 
Glasgow et al. 41 2011 USA RCT Primary care clinic 270 The objective was to report on the use of the My Path/Mi Camino diabetes self-management 
website among a heterogeneous sample of adults with type 2 diabetes. 
Goeman et al. 42 2013 Australia RCT Home or hospital 123 To improve the asthma control and adherence to medication of older people using the Patient 
Asthma Concerns Tool (PACT) to identify and address unmet needs and patient concerns. 
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Gossey et al. 43 2011 USA RCT Community health center 116 To determine the feasibility of the use of an audio booklet in a community health clinical setting 
with patients from a low health literate population. 
 
Heinric and 
Kuiper 44 
2012 USA UCT Primary care 35 To examine adherence related to the use of handheld devices that delivered electronic medication 
reminders in a sample of adults experiencing a chronic illness. 
 
Hussey 45 1994 USA UCT Geriatric outpatient clinic 80 To evaluate the effectiveness of verbal teaching and of color-coded chart that had been designed to 
tailor medication regimen to elderly persons daily schedule 
 
Jolly et al. 46 1995 USA NRCT Inner-city university hospital 440 To determine whether improvements in comprehension can be achieved by simplification of 
available materials. 
 
Joshi and 
Kothiyal 47 
2011 USA UCT Outpatient hospital 200 To determine whether these pictograms can be effectively understood by illiterate `patients, who 
otherwise cannot read the instructions given on their prescription order 
 
Kalichman et al. 
48 
2005 USA UCT HIV clinic 30 To develop and pilot-test a nurse-delivered counseling intervention designed to improve HIV 
treatment adherence among lower literacy adults receiving antiretroviral therapies 
 
Kalichman et al. 
49 
2013 USA RCT Aids services 446 To test the efficacy of a pictograph-guided adherence skills-building counseling intervention for 
limited literacy adults living with HIV. 
 
King 50 2012 USA NRCT Non-pharmacy education 161 The objective of this investigation was to assess whether short-term recall of pharmacy-generated 
prescription medication information could be enhanced in a low health literate sample through the 
use of symbols. 
 
Kripalani et al. 51  2007 USA RCT Inner city Primary care center 209 To describes the development, implementation, and preliminary evaluation of an illustrated 
medication schedule (a ‘‘pill card’’) that depicts a patient’s daily medication regimen using pill 
images and icons. 
 
Kripalani et al. 52 2012 USA RCT Tertiary care academic 
hospitals. 
862 To determine the effect of a tailored intervention on the occurrence of clinically important 
medication errors after hospital discharge. 
 
Kripalani et al. 53 
 
2012 USA RCT Primary care clinic 440 To test the effect of two low-literacy interventions (Illustrated medication schedule and refill 
reminder post card) on medication adherence 
Lefante et al. 54 2005 
 
USA UCT N/A 844 To assess the impact of medication reviews on patient understanding, compliance, drug-drug and 
drug-disease interactions, and adverse events. 
 
Magadza et al. 55 2009 South 
Africa 
UCT Rhodes University 45 To investigated the effect of an educational intervention on selected hypertensive participants’ 
levels of knowledge about hypertension, their beliefs about medicines, and adherence to 
antihypertensive therapy. 
 
Mansoor and 
Dowse 56 
2003 South 
Africa 
RCT Primary health care clinic 60 To design, develop, and evaluate a simple, understandable medicine label and patient information 
leaflet (PIL) for nystatin suspension, and to assess the effect of incorporating pictograms on 
understanding in low-literate participants. 
McCarthy et al. 
57 
2013 USA RCT Emergency department 3,984 To determine whether prescription information or services improve the medication adherence of 
emergency department (ED) patients. 
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Morrow et al. 58 2005 USA NRCT Clinical setting 32 To investigated whether patient-centered instructions for chronic heart failure medications increase 
comprehension and memory for medication information in older adults diagnosed with chronic 
heart failure.  
 
Morrow et al. 59 2008 USA RCT Community setting 64 Whether an external aid (medtable) supports collaborative planning in the context of a simulated 
patient/provider task in which pairs of older adults worked together to create medication schedules. 
 
Moskowitz et al. 
60 
2013 USA RCT Clinic 299 To examine whether the effect of peer health coaching on hemoglobin A1c (A1c) is modified by 
characteristics that are known to be associated with diabetes control. 
 
Murray et al. 61 2007 USA RCT University-affiliated, inner-
city, ambulatory care practice 
314 To determine whether a pharmacist intervention improves medication adherence and health 
outcomes compared with usual care for low-income patients with heart failure. 
 
Neafsey et al. 62 2002 USA RCT N/A  To describe the effectiveness of a interactive multi- media software program called ‘‘Preventing 
Medicine Conflicts’’ to increase older adults’ knowledge of potential drug interactions arising from 
self-medication, increase their self-efficacy (confidence) in how to avoid such interactions, and 
decrease reported adverse self-medication behaviors. 
 
Negarandeh et al. 
63 
2013 Iran RCT Diabetes clinic 127 To explore the impact of pictorial image and teach back educational strategies on knowledge, 
adherence to medication and diet among patients with type 2 diabetes and low health literacy in 
Saqqez, Iran. 
 
Ngoh and 
Shepherd 64 
1997 USA RCT Health centers 78 To examine the use of Western Medications in three communities in Mezam division in the North-
West province of Cameroon. 
 
Poureslami et al. 
65  
2012 Canada RCT University-based pulmonary 
medicine clinic. 
85 To explore the effectiveness of different formats of culturally relevant information and its impact on 
asthma patients’ self-management within the Punjabi, Mandarin, and Cantonese communities. 
 
Sahm et al. 66 2012 USA RCT Outpatient clinic 94 To assess the efficacy of patient-centered label (PCL) instructions on the knowledge and 
comprehension of prescription drug use compared to standard instructions. 
 
Savas and Evcik 
67 
2001 Turkey RCT Outpatient clinic 91 The aim of our study is to evaluate the effect of written information in improving the knowledge of 
the undereducated nonsteroidal anti-inflammatory drug (NSAID) users about the side effects of 
NSAIDs and to investigate the compliance of patients with the written information materials. 
 
Schillinger  et al. 
68 
2005 USA UCT Hospital clinic 220 To explore whether concordance rates vary when patients report their regimen verbally or identify 
their regimen by use of a visual aid 
 
Tait et al. 69 
 
2012 USA UCT Health care 200 To evaluate and compare subjects’ understanding and perceptions of risks and benefits presented 
using animated computerized text and graphics. 
Unk and 
Brasington 70 
2014 USA RCT Rheumatology clinic 98 To use a multimedia modality to improve medication adherence of patients with rheumatoid 
arthritis. 
 
Van Servelle et 
al. 71 
 
2005 USA RCT Community based clinic 85 The effects of a treatment adherence enhancement program on health literacy, patient-provider 
relationships, and adherence to highly active antiretrovirus therapy (HAART) in a population of 
low income Spanish-speaking Latinos receiving antiretroviral therapy in com- munity-based clinics. 
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Wang et al. 72 2010 USA RCT HIV/AIDS treatment sites, 
including 
116 To examine the effects of nurse-delivered home visits combined with telephone intervention on 
medication adherence, and quality of life in HIV-infected heroin users. 
Watanabe et al. 73 2012 Japan NRCT Outpatient from hospital 38 To examine the effectiveness of the Donepezil Outpatient Consultation Service . 
Wong 74 2006 USA UCT Hospital 34 To examine if culturally sensitive audiovisual patient education program would be of substantial 
and measurable benefit in increasing patient understanding of the concepts of antiretroviral 
medication resistance risk and medication-taking skills. 
 
Zullig et al. 75 2014 USA UCT Hospital-based primary care 
clinics 
23 To determine whether antihypertensive medication adherence could improve using a Meducation1 
technology health literacy intervention. 
 
*Note sample size is population that completed the study 
*RCT=Randomized control trials, NRCT=Non-randomized control trials, UCT= Uncontrolled-trials 
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Table 2.2: Health literacy assessment tool inclusion of low health literate demographic characteristics 
Author Low Health Literacy Risk Factors Health literacy 
assessment tool 
Health literacy 
prevalence 
Number of 
demographic 
included in low 
health literacy 
population 
 50+ in Age Ethnic minority Low Income Low Education    
Aker et al. 29 
 
✔ ✔ 
N/A  REALM 14.3% low literacy 2 
Brock and Smith 34 
✔ ✔ ✔ 
N/A REALM 55% 3 
Cordasco et al. 37 
✔ ✔ ✔ 
N/A TOFHLA 47.1% 3 
Davis et al. 38 
✔ ✔ 
N/A 
✔ 
REALM 15% low literacy 
 
30% marginal literacy 
3 
Dewalt et al. 39 
✔ ✔ ✔ 
N/A STOFHLA 41% Inadequate health 
literacy 
3 
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Dowse and Ehlers 40 
✔ ✔ ✔ ✔ 
Short readability 
literacy test  
35% 3 
Glasgow et al. 41 
✔ ✔ 
 N/A STOFHLA Average score: 
4.8= inadequate health 
literacy 
2 
Gossey et al. 43 
✔ ✔ 
N/A N/A STOFHLA 31% inadequate health 
literacy 
2 
Heinric and Kuiper 44 
✔ ✔ 
 N/A The Newest Vital 
Sign (NVS) 
 
28.6% limited health 
literacy 
2 
Hussey 45 
✔ ✔ ✔ ✔ 
Reading skills 
assessment  
N/A 4 
Jolly et al. 46 N/A N/A N/A N/A PIAT-R test 31% below 9th grade 
reading level 
1 
Joshi and Kothiyal 47 
✔ ✔ ✔ ✔ 
Reading and writing 
assessment 
All illiterate 4 
 
  
Kalichman et al. 48  
✔ 
N/A N/A TOFHLA 66% average core – 
marginal health 
literacy 
1 
33 
 
Kalichman et al. 49  
✔ ✔ 
N/A TOFHLA 
 
50% <85% score 2 
King 50  
✔ ✔ 
N/A REALM Mean score 24.48 
score – low health 
literate 
2 
Kripalani et al.  51 
✔ ✔ 
N/A N/A REALM 78.5% read at less than 
the 9th grade level 
based on their 
REALM scores 
2 
Kripalani et al. 52 
✔ ✔ ✔ 
N/A STOFHLA 10% inadequate health 
literacy 
3 
Kripalani et al.  53 
✔ ✔ 
N/A 
✔ 
REALM 45.1% <6th grade level 2 
McCarthy et al. 57 
✔ 
 
✔ ✔ 
N/A REALM 38% Reading level 
grade <8  
2 
Morrow et al. 58 
✔ ✔ 
N/A N/A STOFHLA 34% marginal or 
inadequate health 
literacy 
2 
Moskowitz et al. 60 
✔ ✔ 
N/A N/A REALM Mean score 3.6 =     
low literacy 
2 
34 
 
Murray et al. 61 
✔ ✔ ✔ 
N/A STOFHLA 71.3% 3 
Neafsey et al. 62 
✔ ✔ 
N/A N/A REALM N/A 2 
Negarandeh et al. 63 
✔ ✔ 
N/A ✔ TOFHLA Average score of 34= low health literate 2 
Poureslami et al. 65 ✔ ✔ ✔ ✔ 5-point Likert scale health literacy test N/A 4 
Sahm et al. 66 ✔  N/A ✔ REALM 30.9%  2 
Schillinger  et al. 68 ✔ ✔ N/A N/A STOFHLA 48% inadequate health literacy 2 
Tait et al. 69 ✔ ✔ N/A N/A REALM N/A 2 
Van Servelle et al. 71 
 ✔ ✔ ✔ N/A REALM N/A 3 
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 N/A= Not Available information about levels below high school or education in general was not mentioned 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Zullig et al. 75 ✔ ✔ ✔ N/A REALM 40% low health literacy 3  
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Table 2.3: Classification of medication information interventions 
 
Author Written 
information 
Visual 
information 
Verbal 
information 
Medication 
label/bottle 
Reminder 
systems 
Educational 
Programs/ 
services 
Intervention Passive Active Use of 
technology  
Significant 
knowledge 
Significant 
adherence 
Aker et al.  29 ✔  ✔    Simplified written drug 
information  
✔    N/A 
Al-Saffar et 
al. 30 
✔  ✔    Patient information leaflet 
(PIL) 
✔       
Boyne et al. 31 ✔ ✔ ✔   ✔ Telemonitoring device   ✔ ✔   
Braich et al. 32 ✔ ✔ ✔    Pictogram  ✔   N/A 
Brath et al. 33 ✔ ✔   ✔ ✔ Electronic blister pack  ✔ ✔ N/A • 
Brock and 
Smith 34 
✔ ✔ ✔    Digital video   ✔ ✔   
Burghardt,et 
al. 35 
✔ ✔ ✔    Educational board game  ✔   N/A 
Cardarelli et 
al. 36 
 ✔  ✔   Medication bottle color and 
symbol label system 
✔    N/A 
Cordasco et 
al. 37 
✔ ✔   ✔  Low-literacy medication 
education tool 
✔  ✔   
Davis et al.  38 ✔   ✔   Prescription label 
instructions  
✔    N/A 
Dewalt et al. 
39 
✔ ✔ ✔  ✔ ✔ Primary care based heart 
failure self-management 
program 
 ✔   N/A 
Dowse and 
Ehlers 40 
✔ ✔  ✔   Pictograms ✔     
Glasgow et 
al. 41 
✔ ✔ ✔   ✔ Internet based multimedia 
diabetes self-management 
education 
 ✔ ✔ N/A  
Goeman et al. 
42 
✔ ✔ ✔   ✔ Patient asthma concern tool  ✔ ✔   
Gossey et al. 
43 
✔ ✔ ✔    Audio booklet  ✔ ✔  N/A 
Heinric and 
Kuiper 44 
✔    ✔  Handheld device reminder   ✔ ✔ N/A  
Hussey 45 ✔ ✔ ✔  ✔  Picture schedule  ✔    
Jolly et al. 46 ✔      Simplified written 
instructions 
✔    N/A 
Joshi and 
Kothiyal 47 
✔ ✔ ✔    Pictograms ✔    N/A 
Kalichman et 
al. 48 
✔ ✔ ✔  ✔ ✔ Personalized feedback report 
and medication adherence 
action plan 
 ✔    
Kalichman et 
al. 49 
✔ ✔ ✔  ✔ ✔ Pictograph-guided adherence 
skills building counseling 
intervention 
 ✔ ✔ N/A  
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King 50 ✔ ✔     Medication information 
leaflet 
✔    N/A 
Kripalani et 
al. 51  
✔ ✔   ✔  Pill card ✔    N/A 
Kripalani et 
al. 52 
✔ ✔ ✔  ✔ ✔ Pharmacist Intervention for 
Low Literacy in 
Cardiovascular Disease 
(PILL-CVD) 
 ✔  • N/A 
Kripalani et 
al. 53 
 
✔ ✔ ✔  ✔  Illustrated medication 
schedule and refill reminder 
postcard 
 ✔  N/A  
Lefante et al. 
54 
✔  ✔   ✔ Medication reviews  ✔  N/A  
Magadza et 
al. 55 
✔ ✔ ✔   ✔ Pharmacist initiated 
education 
 ✔    
Mansoor and 
Dowse 56 
✔  ✔ ✔ ✔  Medicine label and patient 
information leaflet 
✔    N/A 
McCarthy et 
al. 57 
✔ ✔ ✔  ✔ ✔ Prescription information and 
service 
 ✔  N/A  
Morrow et al. 
58 
✔ ✔     Patient centered instructions ✔    N/A 
Morrow et al. 
59 
✔ ✔ ✔  ✔  Medication schedule ✔    N/A 
Moskowitz et 
al. 60 
  ✔    Health coach  ✔   N/A 
Murray et al. 
61 
✔ ✔ ✔ ✔   Pharmacist based 
intervention 
 ✔  N/A  
Neafsey et al. 
62 
✔ ✔ ✔   ✔ Patient education program  ✔ ✔  N/A 
Negarandeh 
et al. 63 
 ✔ ✔   ✔ Teach back and Pictorial 
image  
 ✔    
Ngoh and 
Shepherd 64 
✔ ✔ ✔    Culturally tailored visual aid  ✔    
Poureslami et 
al. 65  
✔ ✔ ✔    Educational video and 
pictorial pamphlet 
 ✔ ✔   
Sahm et al. 66 ✔ ✔  ✔   Patient centered instructions ✔    N/A 
Savas and 
Evcik 67 
✔  ✔    Written and verbal 
information  
 ✔   N/A 
Schillinger  et 
al. 68 
 ✔     Digital tablets ✔  ✔   
Tait et al. 69 
 
✔  ✔    Animated computer-
generated text and graphics 
 ✔ ✔ • N/A 
Unk and 
Brasington 70 
✔ ✔ ✔   ✔ Multi-dimensional education 
program 
 ✔ ✔ N/A  
Van Servelle 
et al. 71 
 
✔ ✔ ✔   ✔ Treatment adherence 
enhancement program  
     
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Wang et al. 72 ✔ ✔ ✔  ✔ ✔ Nurse delivered home visit + 
telephone calls 
 ✔ ✔ N/A  
Watanabe et 
al. 73 
  ✔   ✔ Outpatient consultation 
service 
 ✔    
Wong 74  ✔ ✔    Culturally sensitive 
educational videotape 
 
✔  ✔  N/A 
Zullig et al. 75 ✔ ✔ ✔  ✔  Medication technology  ✔ ✔ N/A  
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              Table 2.4: Primary outcome measure of knowledge and adherence  
 
Author Subjects Health literacy 
assessment tool 
Health 
literacy 
prevalence 
Intervention Outcome measure 
 
 
Effectiveness 
 Gender Age Ethnic Income Education    Type Outcome 
measure tool 
 
Aker et al. 29 
 
50.5% 
woman 
61% 45- 64, 
 
20% 
African 
American 
N/A 
 
 
 
 
 
 
 
28% high 
school or less 
education 
 
 
REALM 
 
 
 
 
 
 
 
14.3% low 
literacy 
 
 
 
 
 
 
Simplified 
written drug 
information 
Knowledge 
 
 
 
 
 
 
 
 
 
Questionnaire 
 
 
Improvement 
 
 
 
Al-Saffar et al. 30 33 females 
67 males 
17( 6%) Kuwaiti 165 (59%) 14% no 
education 
Demographic 
characteristic: 
age, ethnicity, 
income 
 
(Population 
demographics) 
N/A Patient 
information 
leaflet (PIL) 
Adherence 
 
 
 
Knowledge 
 
 
 
 
 
 
 
 
Self report 
and pill count 
 
 
Questionnaire 
 
 
 
 
 
 
 
Significant 
improvement 
 
 
Statistically 
significant 
improvement 
Boyne et al. 31 59.1% male Mean age 71 
years old 
Netherlands 
 
N/A 33.6% 
primary 
school 
Socio-
demographics 
N/A Telemonitoring 
device 
Knowledge 
 
 
 
Adherence 
Questionnaire 
 
 
 
Heart Failure 
Compliance 
Statistically 
significant 
improvement 
Improvement 
40 
 
Scale 
Braich et al. 32 
 
141 Female 
84 males 
N/A Indian N/A 150 receiving 
no education 
Education and 
geographical 
location 
(Population 
demographics) 
Majority Pictograms Knowledge Oral exam 
 
Statistically 
significant 
improvement 
Brath et al. 33 57% female Mean age 
69.4 years old 
European N/A N/A Socio-
demographic 
characteristic 
N/A Electronic 
blister pack 
Adherence 
 
 
 
 
Electronic 
blister pack 
Statistically 
significant 
improvement 
Brock and Smith 
34 
Male (51%) 42.1 years 
average 
(25-70 range) 
77% 
African 
American 
English 
speaking 
65% low 
income 
60% 
completed 
high school 
REALM 55% Digital video on 
PDA 
Knowledge 
 
 
 
 
Adherence 
 
 
Questionnaire 
 
 
 
 
Self-report 
 
 
 
 
Statistically 
significant 
improvement 
 
 
Statistically 
significant 
improvement 
 
 
Burghardt et al. 35 
 
 
 
 
 
121 
females 
64 males 
83 (44.4% -
45-64 
 
20 (107%) -
65+ 
95.6% 
African 
American 
43.7% in 
poverty 
25.4% no 
high school 
diploma 
 
 
 
 
 
Population 
demographics 
50% 
 
 
 
 
 
Educational 
games 
 
Knowledge 
 
 
 
 
 
Verbal 
questionnaire 
 
 
 
 
 
Statistically 
significant 
improvement 
 
 
 
 
 
 
Cardarelli et al. 36 44 female 
56 males 
Mean age 
73.4 
82% 
Caucasian 
17%- 
African 
American 
and 
Hispanic 
N/A 8% less than 
high school 
Population 
demographics 
N/A Medication 
bottle color 
symbol label 
system 
Knowledge 
 
 
 
 
 
 
 
 
 
Pre and post 
medication 
identification 
test 
 
 
 
Statistically 
significant 
improvement 
41 
 
Cordasco et al. 37 38.9% 
female 
 
Mean age 
55.8 
75% 
Hispanic 
13.3% 
African 
American 
 
(73.5% 
foreign 
born) 
30.4- 
Medicaid 
60.1% less 
than high 
school 
 
(go back and 
look at details 
and add if u 
can) 
TOFHLA 47.1% Low-Literacy 
Medication 
Education Tool 
for 
Knowledge 
 
 
 
 
Adherence 
Verbal 
questionnaire 
 
 
 
Self reported 
pill count 
Improvement 
 
 
 
 
Improvement 
Davis et al. 38 72% female Mean age 
48.4 years 
61% 
African 
American 
N/A 60% high or 
less education 
REALM 15% low 
literacy 
 
30% 
marginal 
literacy 
Prescription 
label 
instructions 
Knowledge 
 
Verbal 
questionnaire 
Statistically 
significant 
improvement 
Dewalt et al. 39 49% males Mean age 62 55% 
African 
American 
68% less 
than 
<$15,000 
income 
Average 9 
years of 
education 
STOFHLA 41% 
Inadequate 
health 
literacy 
 
 
 
 
Primary care-
based heart 
failure self-
management 
program 
 
Knowledge  
 
 
 
 
 
 
4 point Likert 
scale 
questionnaire 
Statistically 
significant 
improvement 
Dowse and Ehlers 
40 
93% 
females 
33% between 
41-65+ 
84% Xhosa 
ethnic 
group 
(African) 
Most low 
income 
75% less than 
4 years of 
education 
Short literacy 
test 
35% Pictograms Knowledge 
 
 
 
Adherence 
 
 
Questionnaire 
 
 
 
Self reported 
pill count 
Improvement 
 
 
 
Improvement 
Glasgow et al. 41 130 
(48.1%) 
female 
 
 
57.8 average 
age 
4.2% 
American 
Indian 
 
1.5% Asian 
 
18.1% 
African 
American 
 
22.3% 
Latino 
=46.1% 
44.8% 
<$49,999 
20.4% high 
school or less 
STOFHLA Average 
score: 
4.8= 
inadequate 
health 
literacy 
Internet-based 
multimedia 
diabetes self-
management 
education 
Adherence 
 
 
 
 
 
 
 
 
 
Hill-Bone 
Compliance 
Scale 
 
 
 
 
 
 
 
 
 
 
Statistically 
significant 
improvement 
42 
 
Goeman et al. 42 89 (72.3%) 
female 
68 average 
age 
79.6% born 
in Australia 
or New 
Zealand 
27.6% 
<$24000 
43.9% high 
school or less 
Demographic 
characteristic: 
age * 
(mentioned 
Majority Patient Asthma 
Concerns Tool 
(PACT) 
Adherence 
 
 
 
 
Knowledge 
Tracking 
device 
 
 
 
Questionnaire 
Improvement 
 
 
 
 
Improvement 
 
Gossey et al. 43 79 (68.1%) 
females 
55-58 average 
age 
60 (51.7%) 
African 
American 
 
56  (48.3%) 
Hispanic 
N/A 52.6% less 
than high 
school 
STOFHLA 31% 
inadequate 
health 
literacy 
Audio booklet Knowledge 
 
 
 
 
 
 
 
 
Questionnaire 
 
 
 
 
 
Statistically 
significant 
improvement 
Heinric and 
Kuiper 44 
83.8% 
females 
 
16.2% 
males 
58.6 average 
age 
70.3% 
white 
 
27% black 
 
2.7% 
Native 
American 
 42.9% high 
school or less 
The Newest 
Vital 
Sign (NVS) 
 
28.6% 
limited 
health 
literacy 
Handheld 
device 
technology 
Adherence 
 
 
 
 
On Time Rx 
on handheld 
device 
Improvement 
 
 
Hussey 45 30% male Average age 
80 
62% 
African 
American 
100% less 
than $10, 
552 income 
a year 
Average of 8 
years of 
education 
Reading skills 
grade 3-4 
N/A Colour-coded 
daily schedule 
chart (Picture 
schedule) 
Knowledge 
 
 
 
 
 
 
 
Adherence 
Medication 
knowledge 
and 
compliance 
scale 
(MKCS) 
 
 
MKCS 
Statistically 
significant 
improvement 
 
 
 
 
 
Statistically 
significant 
improvement 
 
Jolly et al. 46 N/A N/A N/A N/A 35.5% high 
school or less 
PIAT-R test 31% below 
9th grade 
reading 
level 
Simplified 
written 
instruction 
Knowledge Knowledge 
test 
No 
improvement 
Joshi and Kothiyal 
47 
116 (58%) 
females 
 
84 (42%) 
males 
29.5% 50+ Indian 98% 
<$10,000 
Rs 
N/A Literacy 
assessment not 
mentioned 
All 
illiterate 
Pictograms Knowledge Label 
interpretation 
test 
Improvement 
43 
 
Kalichman et al. 48 33% female Mean age 
44.8 years old 
90% 
African 
American 
N/A 10.4 mean 
years of 
education 
TOFHLA 66% 
average 
core – 
marginal 
health 
literacy 
Personalized 
Feedback 
Report and 
Medication 
Adherence 
Action Plan 
Knowledge 
 
 
 
 
 
 
 
Adherence 
Questionnaire 
 
 
 
 
 
 
 
Self -reported 
pill count 
Statistically 
significant 
improvement 
 
 
 
 
 
Statistically 
significant 
improvement 
 
Kalichman et al. 49 136 (30.5% 
females) 
 
310 
(69.5%) 
males 
47 average 
age 
421 
(94.4%) 
African 
American 
317 (71%) 
<$10,000 
Average less 
than 12 years 
TOFHLA 
 
50% <85% 
score 
Pictograph-
guided 
adherence 
skills-building 
counseling 
intervention 
Adherence Telephone- 
based pill 
count 
Statistically 
significant 
improvement 
King 50 85 (52.8% 
females 
 
76 (47.2%) 
males 
Average age 
33.8 
African 
American 
85% 
N/A 75.8% less 
than high 
school 
education 
REALM Mean score 
24.48 score 
– low 
health 
literate 
Medication 
Information 
Leaflet 
Knowledge Questionnaire No 
improvement 
Kripalani et al. 52 363 (42.1) 
females 
 
499 males 
(57.9%) 
Average age 
59-61 
Black 
(17.2%) 
4% 
<$10,000 
income 
N/A STOFHLA 10% 
inadequate 
health 
literacy 
PILL-CVD 
(Pharmacist 
Intervention for 
Low Literacy in 
Cardiovascular 
Disease) 
Knowledge Medication 
Understandin
g 
Questionnaire 
Statistically 
significant 
improvement 
Kripalani et al. 53 242 
females 
(55.6%) 
Average age 
63.7 
African 
American 
(91%) 
N/A Average 10.9 
years of 
education 
REALM 45.1% <6th 
grade 
Illustrated 
medication 
schedule and 
refill reminder 
post card 
Adherence 4-item 
Morisky 
Medication 
Adherence 
Scale 
(MMAS) 
Improvement 
Lefante et al. 54 74.9% 
female 
Mean age 
66.2 
African 
American  
33.8% 
N/A Average 9.9 
years of 
education 
Demographics 
characteristics 
N/A Medication 
reviews 
Knowledge 
 
 
Adherence 
Verbal 
questionnaire 
 
Verbal 
questionnaire 
Improvement 
 
 
Statistically 
significant 
improvement 
Magadza et al. 55 34 (76%) 
females 
 
11 (24%) 
males 
46% between 
51-60 years 
old 
91% black 
(South 
African) 
N/A 96% less than 
grade 12 level 
Socio-
demographic 
characteristic- 
language 
N/A Pharmacist 
initiated 
education 
intervention 
Patient 
knowledge 
 
 
 
Adherence 
Verbal 
questionnaire 
 
 
 
Self-reported 
Statistically 
significant 
improvement 
 
 
Statistically 
44 
 
verbal 
questionnaire 
significant 
improvement 
 
Mansoor and 
Dowse 56 
65% female 16.7% over 
40 
84% Xhosa 
(South 
African) 
 
 
N/A 100% grade 7 
or less 
Socio-
demographic 
characteristic 
N/A Medicine label 
and patient 
information 
leaflet 
Knowledge 
 
 
 
Questionnaire Statistically 
significant 
improvement 
McCarthy et al. 57 N/A 17.6% over 
the age of 55 
 
 
44% black 
 
3386 
N/A 62.7% grade 
12 or less 
education 
REALM Reading 
level grade 
8 or less 
Prescription 
information and 
services 
Adherence Self-reported 
medication 
adherence 
Statistically 
significant 
improvement 
Morrow et al. 58 24 females 
(75%) 
 
8 males 
(25%) 
Average age 
63.9 
62.5% 
black 
N/A Average of 
11.5 years of 
education 
STOFHLA 34% 
marginal or 
inadequate 
health 
literacy 
Patient centered 
instructions 
Knowledge Questionnaire Statistically 
significant 
improvement 
Morrow et al. 59 52% female Average age 
69 
N/A  Average 14.9 
years of 
education 
Demographic 
characteristic 
N/A Medication 
schedule 
Knowledge Medication 
problem test 
Statistically 
significant 
improvement 
Murray et al.  61 66.9% 
females 
Mean age 62 49.4% 
black 
34% with 
Medicare 
insurance 
(low 
income) 
Average 11 
years of 
education 
STOFHLA 71.3% Pharmacy based 
program 
Adherence  
 
 
 
 
 
Medication 
Event 
Monitoring 
System 
(MEMS) 
 
 
 
Statistically 
significant 
improvement 
Neafsey et al. 62 73% female Mean age 
73.8 
Largely 
Caucasian 
N/A Mean years of 
education 
12.6 
REALM Inclusion 
criteria 
must be 
above 
grade 6 
level 
Personal 
education 
program 
Knowledge 
 
 
 
 
 
 
 
Knowledge 
test 
 
 
Statistically 
significant 
improvement 
45 
 
 
Negarandeh et al. 
63 
58 (45.7%) 
females 
Mean age 
50.13 years 
old 
Iranian N/A 79.5% 
primary 
education 
TOFHLA Average 
score of 34 
(low health 
literate) 
Pictorial image 
and teach back 
Knowledge 
 
 
 
 
 
Adherence 
Self-
structured 
questionnaire 
 
 
 
Self-reported 
Statistically 
significant 
improvement 
 
 
 
Statistically 
significant 
improvement  
 
Ngoh and 
Shepherd 64 
100% 
females 
17% over 39 
years old 
Cameroon - 
West 
Africa 
N/A 87% less than 
7 years of 
education 
Demographic 
characteristics 
N/A Culturally 
tailored visual 
aid 
Adherence 
 
 
 
 
Knowledge 
Pill count 
 
 
 
 
Questionnaire  
 
Statistically 
significant 
improvement 
 
 
Statistically 
significant 
improvement 
 
Poureslami et al. 
65 
50.6% 
females 
 
49.4% 
males 
Mean age 
62.9 years old 
49% 
Chinese 
 
51% 
Punjabi 
29.4% 
unemploye
d 
42.4% 
completed 
elementary 
school 
Questionnaire N/A Educational 
video and 
pictorial 
pamphlet 
Knowledge 
 
 
 
 
 
Adherence 
Questionnaire 
using 5-point 
Likert scale 
 
 
 
Self reported 
Statistically 
significant 
improvement 
 
 
 
Statistically 
significant 
improvement 
 
Sahm et al. 66 31.9% 
males 
54.2% over 
46+ years old 
Irish N/A 33.7% 
Secondary or 
less education 
REALM 30.9% 
below 
secondary 
education 
Patient centered 
instructions 
Knowledge Interpretation 
questionaire 
Statistically 
significant 
improvement 
Savas and Evcik 67 79.1% 
females 
Average age 
50 years old 
Turkish N/A Nearly 50% n 
educated at 
the primary 
school level 
or less 
Socio-
demographics 
Nearly 50% Written and 
verbal 
information 
Knowledge Verbal 
questionnaire 
Statistically 
significant 
improvement 
46 
 
Schillinger  et al. 
68 
50% male Median age 
59 
39% Asian 
14% Black 
28% Latino 
N/A N/A STOFHLA 48% 
inadequate 
health 
literacy 
Verbal and 
visual aid 
Knowledge Questionnaire 
 
 
 
 
 
Adherence 
Statistically 
significant 
improvement 
 
 
 
Statistically 
significant 
improvement 
 
Unk and 
Brasington 70 
87.8% 
females 
Mean age 
50.3 years old 
30.3% 
black 
50.6% less 
than 
$25,000 
income 
37.6% high 
school or less 
education 
Socio-
demographics 
N/A Multidimension
al education 
program 
Adherence 
 
 
 
 
 
 
 
Medication 
Self-
Assessment 
Questionnaire 
(MAQ) 
 
 
 
No 
improvement 
Van Servelle et al. 
71 
 
90.7% male Mean age 
40.7 years old 
75.3% 
Spanish 
50% 
reported 
income of 
$6000 a 
year 
81% less than 
high school 
education n 
REALM N/A Treatment 
adherence 
enhancement 
program 
Knowledge 
 
 
 
 
Adherence 
 
 
 
 
Survey 
 
 
 
 
Self reported 
Statistically 
significant 
improvement 
 
 
Statistically 
significant 
improvement 
Wang et al. 72 83.6% male Mean age 
36.7 
Chinese Eighty-
seven 
subjects 
(75%) low 
income 
53.4% middle 
school or 
below 
education 
Socio-
demographics 
N/A Nurse-delivered 
home visits + 
telephone calls 
Adherence 
 
 
 
 
 
 
 
 
 
 
 
CPCRA 
Antiretroviral 
Medication 
Self-Report. 
 
 
 
 
 
 
 
Statistically 
significant 
improvement 
Watanabe et al. 73 19 (52.8%) 
male 
Average age 
77.7 years old 
Japan N/A N/A Socio-
demographics 
N/A Outpatient 
Consultation 
Service 
Knowledge 
 
 
 
 
 
 
 
 
Survey 
 
 
 
 
 
 
 
 
Statistically 
significant 
improvement 
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Adherence 
 
 
 
In clinic 
check 
 
 
 
Statistically 
significant 
improvement 
 
Wong 74 28 (82.3%) 
female 
Mean age 
31.2 years old 
South 
African 
N/A Mean of 8.8 
years of 
education 
Social 
demographics 
N/A Culturally 
sensitive 
educational 
videotape 
Knowledge Questionnaire Statistically 
significant 
improvement 
Zullig et al. 75 91% male Mean age 
66.6 
61% 
African 
American 
31% 
inadequate 
income 
9% 
completed 
less than high 
school 
REALM 40% low 
health 
literacy 
Medication 
technology 
Adherence 
 
 
 
 
 
Self-reported 
and 
medication 
possession 
ratio [MPR] 
of <80%) 
 
 
 
 
Statistically 
significant 
improvement 
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Chapter 3: Don’t assume the patient understands: Qualitative 
analysis of low health literate patient insight to challenges 
faced with medication information at the pharmacy 
3.1. Introduction 
 
Good communication between pharmacists and patients is fundamental for the safe and 
effective use of medications.
1
 To ensure patients can take their medication as prescribed, 
they must have at minimum the basic understanding of how to take their medication, and 
be able to recognize the risks and benefits of their prescriptions.
2
 Yet, an estimated 50% 
of individuals with chronic disease struggle to take their medication as prescribed.
3
  
 
The World Health Organization (WHO) has identified low health literacy is a primary 
patient-related factor contributing to medication non-adherence.
11
 Low health literacy 
populations have difficulty understanding health information and making appropriate 
health decisions.
4
 Patients with low health literacy skills are 10 to 18 times less likely to 
correctly identify all their medication, in comparison to those with adequate health 
literacy skills (p<0.05).
5
 Low health literacy is associated with higher hospitalization and 
emergency care use, lower use of diagnostic and screening tools, lower ability to interpret 
and understand medication instructions, poorer health status and higher mortality.
6
 
Additionally, low health literate individuals are more likely to have difficulty 
understanding medication information which includes medication labels, auxiliary labels, 
instructions and written and verbal information.
7,
 
8,
 
9
  Yet, these pharmacy education tools 
are the primary means for educating patients about medication.  
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A conceptual model developed by Baker (2006) describes health literacy in the real-
world as the result of the individual’s capacity to understand health information that is 
provided by the health care system.
10 
 Baker's model underlines that the health care 
system has the responsibility to provide health-specific knowledge to ensure patients can 
self-manage their health.
10,11
 Yet, current medication information is too complex and 
prevents low health literate populations from self-managing their health. This struggle 
highlights the need for health care systems to recognize and address the challenges 
patients face when trying to understand medication. Therefore, the objective of the study 
was to explore the major challenges low health literate adults face when trying to 
understand their medication therapy.   
3.2. Material and methods 
 
Ethics approval from the University of Waterloo Research Ethics Board (Approval 
#19364) was obtained prior to conducting research. The consolidated criteria for 
reporting qualitative research (COREQ) checklist was used to report the results 
(Appendix 1).
12
 
 
One-on-one semi-structured interviews were used to gather data on the major challenges 
low health literate adults face regarding their medication. Each interview began with a 
verbal health literacy assessment, followed by open-ended questions focused on 
medication information. After each interview was complete, a written health literacy 
assessment was given, which was later used to compare self assessed health literacy to 
written health literacy scores. All interviews were audio-recorded, transcribed and 
analyzed using thematic analysis.  
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3.2.1. Population sample 
 
Participants were recruited using a purposive intensity sampling approach.
13
 The sample 
included adults over the age of 50 who speak English as an alternate language. The 
participants also included a range of adults who were healthy and who were living with 
impaired mobility, health and/or cognition. Intensity sampling was chosen to ensure that 
the data reflected a wide range of incomes, ethnic/racial minorities and older adults.
19
  
3.2.2 .Recruitment 
 
Participants were recruited from Northwood Neighbourhood Services seniors programs 
held at five different locations in the Greater Toronto area. Interviews were conducted at 
five locations and included a Latin American seniors program, a Vietnamese and Chinese 
seniors program, an Albanian seniors program and two multicultural seniors programs. 
At each program, a female researcher (HW) verbally introduced herself by reading the 
recruitment script, which invited participants to engage in a thirty-minute interview 
exploring the challenges they face with medications. No previous relationship was 
established prior to research. Each participant was given the option to have an accredited 
interpreter present during the interview. Participants wishing to leave the study were to be 
documented and their data were excluded and destroyed, but none withdrew. If a 
participant did not speak English, the interpreter helped explain the research objective 
and obtained informed consent, meaning the participant signed the consent form stating 
they understood the study and willingly consented with full understanding. The 
interpreter was also required to complete a contractual agreement not to breach the 
subject’s privacy and confidentiality.  
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3.2.3. Interview 
  
The one-on-one semi-structured interviews took place in a private area within the seniors 
program facilities, to ensure information was kept confidential and to obtain a clear audio 
recording. The interview began with subjects verbally self-assessing their health literacy 
levels through a series of brief screening questions focused on medication and health 
information.
14
 Throughout the interview, research questions were open-ended to promote 
a conversation where the participant communicated for the majority of the interview, 
while the interviewer listened, encouraged storytelling and asked probing questions. At 
the end of the interview participants were asked a series of demographic questions that 
included age, gender, language, education, and computer or smartphone usage. 
Interviews were conducted until saturation was met and no new information or themes 
were being observed.
13 
 3.2.4. Health Literacy Assessment 
 
At the start of each of interview, participants were asked the following verbal assessment 
questions to gauge their health literacy using a 5-point Likert scale: 1) how often do you 
have someone help you read materials about your medications; 2) how confident are you 
filling out medical forms by yourself, and; 3) how often do you have problems learning 
about your medications because of difficulty understanding written information.
14
 At the 
end of each interview, a Short Test of Functional Health Literacy Assessment 
(STOFHLA) was administered.
14
 The STOFHLA provided a quick and efficient way of 
determining the participant’s health literacy level.14 In the STOFHLA, participants are 
given a 7-minute time limit to complete 36 multiple-choice questions using a modified 
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cloze procedure, where every fifth to seventh word is absent and participants must 
determine the correct word from a set of four multiple choice options.
14 
3.2.5. Analysis 
 
After the interviews were completed, each interview was transcribed and interviews that 
included an interpreter were documented and transcribed in the English interpretations.  
Transcripts were uploaded and analyzed in NVivo (version 10.0.418.0 Melbourne, 
Australia, QSR International). Analysis included the following stages: 1) open coding 
where large number of initial data were focused and labeled into concepts, 2) category 
development coding where open coding results were re-examined and further 
concentrated, and 3) thematic coding where previous codes were placed into themes.
15
 To 
minimize bias, two authors independently coded the first three transcripts and compared 
their codes to develop a code book. From that point, the remaining transcripts were coded 
by a single author and reviewed with a second author. 
3.3. Results 
 
3.3.1. Participant characteristics   
 
We reached saturation after 20 interviews. The participant ages ranged from 52-80 years 
old and had a mean age of 67 years old. The sample was 60% female and 40% male, and 
90% had been educated outside of North America. On average, 85% of the population 
had less than a high school level of education from their country of origin.  The 
population consisted of a variety of ethnic/racial groups, including Chinese, Vietnamese, 
Spanish, Afghan, Armenian, Italian, Albanian, Indian, Iranian and Somali. Additionally, 
in regards to health literacy, 75% of the population was classified as low health literate 
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based on the STOFHLA. Additionally, participants in the study generally over estimated 
their health literacy levels on the verbal brief health literacy screen tests in comparison to 
the scores on the STOFHLA. 
3.3.2. Qualitative analysis  
 
After thematic analysis, a flow chart that describes the low health literate population’s 
pharmacy experience with medication information was developed to explain the cause 
and effect of challenges faced with current pharmacy medication information (Figure 
3.1).  The flow chart consisted of 3 themes (factors, results, outcome) and 5 categories 
(challenges, barriers, seeking help, unknown, medication related outcomes), where each 
category fell into one of the three themes. Challenges and barriers were factors, seeking 
help and the unknown were results and medication related outcomes were the outcomes 
of current medication information. flow chart began with identifying all sources of 
medication information from the pharmacy. The flow chart demonstrates that current 
challenges the low health literate populations face with  medication information from the 
pharmacy are caused by encountered barriers. When low health literate individuals face 
challenges with medication information they seek additional help from other sources and 
attempt to address their challenges. When challenges are still present, low health literate 
populations are left with unanswered questions or concerns, which lead to the perception 
of negative medication related outcomes.  
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Figure 3.1: Low health literate population's pharmacy 
experience with medication information 
 
3.3.3 Current information from the pharmacy 
 
Throughout the interviews participants reported that they currently receive a variety of 
different sources of information. This information was grouped into pharmacy counseling 
and information provided for reference at home.   During pharmacy visits, participants 
indicated that they received pharmacy counseling generally when they had a new 
prescription.  Medication information provided for reference at home included patient 
handouts, prescription label instructions and auxiliary labels. Most participants were 
unhappy with the current patient handout. Correspondingly, a 63-year-old male 
participant from India said, 
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“They put too much information there which may or may not be useful to 
you, I think because they want to save themselves from legal problems. 
Sometimes the information is overwhelming.” 
Participants highlighted their dependence on prescription label instructions as their major 
source of medication information. Specifically, most participants were grateful for 
auxiliary labels that indicate important instructions for the participant to follow. 
Participants paid close attention to auxiliary labels, as they would visually see the labels 
every time they took their medication. Further, because the pharmacist took the time to 
add the auxiliary label to the bottle, this signified the importance of the highlighted label. 
Several participants also indicated that they relied on the picture on the auxiliary label 
because of difficulty reading English and the small font size.  A 72-year- old female 
participant from Armenia commented,  
“Pictures it makes it very easy, there is no need for you to read it, just you 
see the picture and it explains everything, see drink with water, take with 
food.” 
3.3.4. Factors with current medication information 
3.3.4.1. Challenges 
 
A challenge is defined as a difficulty encountered by a patient. In response to the question 
“What challenges do you face with your medication,” four types of challenges were 
identified, including understanding, forgetting, side effects and food 
instruction/interactions.  
A common challenge amongst participants was the difficulty in understanding medication 
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information provided by the pharmacy, including counseling, prescription labels and 
patient handouts. Most participants attributed their difficulties to the time constraint of 
the pharmacist and the complex language in the patient handout. Current information 
received from the pharmacy is not sufficient for the patient to self-manage their own 
health. A 72-year-old male from India stated,  
“How can I take care of myself, if I don’t know what to do. When I take my 
medication I feel I take a chance because I don’t know if I’m doing it right.” 
In the low health literate population, a consistent challenge encountered was forgetting to 
take their medication, as well as forgetting medication information, such as when to take 
their medication, whether to take it on a full or empty stomach and what the medication is 
for.  A 56-year-old male from Italy said, 
“Oh I miss my medication so many times. I would be at home watching TV 
and I forget to take my medication. I would forget to take it with me when 
I’m working and sometimes I go somewhere and forget.” 
Additionally, most participants highlighted their concern with side effects and food 
interactions. Most participants were concerned they were not given enough information 
to decide what foods and beverages to avoid while taking their medications, how many 
hours before and after they can consume certain food and beverages and whether their 
medication should be taken on a full or empty stomach. Several participants also 
indicated that they base the decisions about what foods to avoid on personal experience, 
and culture. Several participants shared many side effects and food restrictions not 
mentioned by the pharmacist, which they believed led to unwanted side effects. A 66-
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year-old Italian male, was asked to share any experience faced with side effects and food 
and quoted,  
“Yes grapefruit, I experienced myself because sometimes I had half 
grapefruit and then one day I could not walk and I say what happened. What 
happened to me than I mention to doctor and the pharmacist said no 
grapefruit! They no tell me, the pharmacist after this happened told me and 
put a sticker on my bottle.” 
3.3.4.2. Barriers 
 
A barrier is defined as a limitation or boundary that restrains the progress of a patient. 
Barriers encountered by the participants were time, communication, memory and support. 
A recurrent barrier identified throughout the interviews was the limited time and 
interaction available with the pharmacist. Pharmacists were described to be extremely 
busy and determined to finish counseling in the least amount of time possible. A 54 year-
old woman from Vietnam commented, 
“The pharmacist just want to finish their time and rush you through the 
door because no time and that makes the patient feel uncomfortable.” 
Some participants expressed the belief that the pharmacist wants to help and give the 
patient their time, but because of the high demand for their assistance they are unable to 
provide sufficient time to every customer. However, some participants found the time 
constraint prevented them from asking questions or clarifying instructions. 
Communication was not limited to merely verbal communication but also written text.  
Most participants described verbal communication between patient and pharmacist to be 
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rushed due to time limitation and also found the patient handout to be complex and 
unappealing: 
“There are so many technical, medical words they use I don’t understand 
and sometimes it’s not easy to follow the instructions I get when I go home on 
that paper.” 
The participants in the study all spoke some English as a second language and found 
communication to be a barrier because they did not speak English as a primary language. 
Participants indicated they did not feel confident in asking the pharmacist questions or 
asking for clarification because of the feeling of the pharmacist not understanding them. 
Several participants commented on feeling embarrassed because of a heavy accent or not 
speaking English perfectly and felt hesitant to speak to the pharmacist. 
Several participants believed that pharmacist “didn’t care” about their medication needs 
because the pharmacist would only speak to the participant when they were picking up a 
new medication and would not ask any follow-up questions. A 66-year-old Spanish male 
commented, 
“I don’t even know my pharmacists name, he just gives me my medication 
and I leave. We barely talk at all.”  
However, participants who received support from their pharmacist had fewer challenges 
with their medications and would take their medication regimens very seriously.  
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3.3.5. Results of current medication information 
3.3.5.1. Seeking help 
 
Other than medication information provided by the pharmacy, participants shared several 
other sources of information. Participants indicated that they seek help from pharmacists, 
physicians, family, friends, Internet or seek no help.  Participants indicated seeking help 
from pharmacist and physicians during their next visit and through a phone call. Most 
participants preferred having a family member present or independently sending the 
family member to pick up their prescription medication. Participants highlighted the high 
dependence they have on their family members to disclose all information obtained from 
the pharmacy to them in their first language. A general concern was that information may 
be lost in translation and not provided by the pharmacist or family member. Although 
pharmacists provided counseling and prescription monographs, participants still felt the 
need to seek additional information from the Internet. A 72-year-old female participant 
from Chile quoted, 
“We don’t get the information from pharmacist because he doesn’t tell us or 
understand, so my son find on the Internet. He writes it to me on a paper and 
I put it on the fridge.” 
3.3.5.2. The unknown and risks 
 
A primary concern was the unknown information. Participants did not know but were 
interested in understanding the side effects, medication schedule, foods to avoid, why 
they are taking their medication, the benefit of taking their medication and consequences 
related to not taking medication. A 56-year-old Afghan female commented, 
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“I know it’s for thyroid. Now, you can ask me exactly what my thyroid does, 
exactly what it controls, why I take it, and how it works I have absolutely no 
idea...but why don’t they tell me.” 
Participants frequently shared their frustration with the unknown medication information 
blaming their pharmacists and doctors for not disclosing all the necessary information to 
self-manage their medication.  
3.3.6. Outcomes of current medication information 
 
Participants attributed the unknown medication information to several negative outcomes 
including adverse events, their need to assume instructions, their need to refer to 
unreliable sources of information, errors and apathy towards their treatment 
3.4. Discussion  
The present study was designed to explore the major challenges low health literate 
populations face with medication information, specifically adults over the age of 50, who 
speak English as an alternate language. Overall, the results of this study found the major 
challenges to be time, understanding medication information, forgetting to take 
medication, side effects and food-drug interactions. To our understanding, this study was 
the first initiative to develop a flow chart demonstrating the low health literate 
populations associated factors, results and outcomes with current pharmacy medication 
information, based on qualitative interviews. The study demonstrates that a reasonable 
approach to tackle the challenges low health literate populations face with medication is 
for pharmacists to provide more time to patients to convey complex information simply, 
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to build a better relationship with the patient and to repeat medication instruction to the 
patient. 
These results are in agreement with those of previous studies investigating challenges 
patients face with their medication. In the elderly population, research has shown that the 
primary challenges to medication use include side effects, taking too many medications, 
reading medication labels, understanding information and forgetting to take 
medications.
16
 Another study with more focus on ethnic/racial minorities found the 
biggest challenge to be second language issues.
17
 Lastly, in research on individuals with 
chronic conditions, the primary concerns have been found to be side effects, 
remembering and understanding medication regimens.
18
  
According to the low health literate population in this study, current pharmacy 
medication information has not met their standard to ensure the proper self-management 
of medication. One interesting finding in the study was that participants overestimated 
their health literacy levels on the verbal brief health literacy self-assessment screening 
tests in comparison to the scores on the STOFHLA. A possible explanation is that 
participants felt embarrassed and feared being judged on not being able to read, write or 
understanding information. Pharmacists need to be mindful that it can be difficult to 
identify individuals with low health literacy.   
3.4.1. Limitations 
This study has several limitations that should be noted. Although we continued to 
conduct interviews until a saturation point was met, the sample size was small and also 
presented a population of low health literate adults limiting the generalization of the 
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results. Additionally, the use of purposive intensity sampling may impose selection bias 
because the sample was not representative of the entire population, and therefore may not 
be representative of the challenges all patients face with medication information. Further, 
the subjects in our study had their medication costs covered, as Ontarians over the age of 
65 receive provincial drug coverage, which does not represent many international 
audiences who do not have their medications costs covered. Additionally, there is no 
current standardized assessment for health literacy, but of the available assessments, the 
STOFHLA is regarded as the most acceptable and commonly tool for determining health 
literacy.
21
 Another major limitation to this study was that the two individuals who did not 
speak English and required an interpreter were unable to complete the STOFHLA and 
was classified as low health literate for English health literacy.  
3.5. Conclusion 
 
The goal of this study was to identify the challenges low health literate populations face 
at the pharmacy to help guide future development of patient-centered interventions. The 
major challenges patients with low health literacy face at the pharmacy are limited time 
with pharmacists, poor understanding of medication information, forgetting to take 
medications, side effects and food instruction/interactions. In future, effective tools 
should reflect patient preferences, needs, and values, and ensure that patient values guide 
clinical decisions. 
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Chapter 4: The future of pharmacy counseling: Feasibility 
study of providing low health literacy medication counseling 
through NFC-enabled AudibleRx  
 
4.1. Introduction   
 
In North America, pharmacists are typically required to provide patients with medication 
information through clear prescription labels, verbal counseling and patient handouts.
1
 
Yet, in the United States (US), an estimated one third of adults (35%) lack the required 
level of health literacy to necessary to identify what time of day a medication should be 
taken using the instructions on a medication label.
2
 Similarly, in Canada, as many as 60% 
of adults do not have a high enough health literacy to read or act on prescription labels 
and patient handouts, to understand or act on pharmacist counseling or to convey their 
needs to the pharmacist.
3
  
 
Low health literacy is associated with poorer health outcomes and higher hospitalization 
and mortality rates, as well as an increased risk of medication errors.
2
 Low health literacy 
is also closely tied with social inequality and is more common for people who have a 
lower income, lower education, older age or who belong to an ethnic/racial minority 
group.
3
 Health literacy also imposes an economic burden on the healthcare system, 
costing US healthcare payers an estimated $8 billion in healthcare costs.
1 
 
Two recent studies found that the main concerns patients with low health literacy have 
with pharmacy services is that current medication information is difficult to understand, 
and pharmacists have very little time to try to explain medication information in a way 
that is understood.
4,5 
Furthermore, health professionals tend to overestimate a patient's 
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level of understanding because patients are reluctant to disclose their health literacy 
struggles for reasons such as language barriers, fear, shame, and heavy pharmacy 
workflow.
4  
It should be unsurprising then that two strategies commonly used in 
pharmacies to support patients who appear to have difficulty managing medications 
include blister packaging and refill reminders--interventions that both focus on helping 
patients adhere, rather than understand. As of now, there is no widely accepted strategy 
that pharmacists have to help patients with low health literacy understand their 
medications.
5 
 
There are new and novel interventions being tested to improve health literacy in 
pharmacies, though none are widely adopted yet. For example, several studies have 
looked at the effect of illustrated medication schedules that show the patient what their 
medication looks like, what it is used for, and when to take it.
4, 5, 6, 7
 While some versions 
appear to improve knowledge and adherence, one of the challenges with illustrated 
schedules is that any medication change requires that the schedule be revised and 
reprinted, increasing the workload of the pharmacy staff and increasing the risk of patient 
confusion.
5
 Educational programs for topics such as hypertension and diabetes are also 
common and appear to improve medication knowledge and adherence, though such 
interventions require a substantial amount of time and resources.
8-13
   
 
Pharmacists need interventions that can be easily incorporated into a busy pharmacy 
practice.  Mobile information and communication technologies such as smartphones and 
tablet computers may be one of the best tools that have emerged in recent years for 
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patient education.
14
 Mobile devices have already been used to deliver dietary programs 
15
, 
to send text messages for smoking cessation and medication adherence 
16,17,18
, and to 
provide monitoring for patient symptoms, health status and quality of life.
19
 In 
developing countries, mobile health is quickly becoming the main source of 
communication in primacy healthcare.
20
 Further, in the US, 91% of adults are already 
using a mobile device and 67% are using it to access the Internet.
20
 The advantage of 
mobile technologies is that they allow patients to access health information anywhere and 
anytime at their own convenience.  
 
Podcasting has emerged as an innovative approach to convey medication information 
using mobile devices. AudibleRx
TM
 is a pharmacist-managed website that aims to 
provide consumers with web and mobile medication information in an audible format, 
particularly individuals who are challenged with low literacy, visual impairment, or who 
learn better by listening. AudibleRx
TM
 was designed for patients who are picking up a 
new prescription and who may require additional counseling after speaking with the 
pharmacist. The goal of the podcasts is to give patients and caregivers a clearer idea of 
what the prescribed drugs does. AudibleRx
TM
 is not affiliated with or influenced by any 
drug manufacturer or institution, thus maintaining an objective and unbiased approach to 
patient education.  Each counseling session is prepared following a specific template, 
which meets the FDA guidelines on Useful Written Consumer Medication Information 
and is written at a grade 10 level.
21
 The AudibleRx
TM
 website has been certified through 
the Health On the Net (HON) code process and is also a member of the National Council 
on Patient Information and education.  
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One of the challenges with a technology such as AudibleRx
TM
 is that it can be difficult to 
send patients to the correct website. However, this process can be automated. Near-field 
communication (NFC) technology uses short-range wireless technology to allow users to 
receive or exchange data by tapping their device to a small NFC tag.
22
 In pharmacies, 
NFC technology could help patients receive digital information through a very simple 
and accessible method.  For example, if a pharmacist wants to refer a patient to a website 
containing the patient handout, the pharmacist could program the website into a sticker 
containing an NFC chip and adhere the sticker to the pill vial. When the patient’s pill vial 
and mobile device are close together, the mobile device would receive the information 
and automatically load the website.
23
 The advantage of this approach is that it automates 
the transfer of information between the busy pharmacist and the patient who has a lower 
level of health literacy. Further, the patient can easily access the information at their own 
convenience and share the information with relevant friends or family members (Figure 
4.1). Therefore, the objective of this study was to test the feasibility of using an NFC-
enabled medication counseling podcast with patients who have mixed health literacy. 
 
Figure 4.1: Pharmacy prescription bottle with NFC-enabled AudibleRx
TM
 Podcast 
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4.2. Material and methodology 
 
A randomized-controlled study design was used to assess the feasibility of comparing a 
medication counseling podcasts with standard pharmacy care. Ethics approval from the 
University of Waterloo Research Ethics Board (certificate #20525) was obtained prior to 
conducting research. 
4.2.1. Development of the Intervention 
 
The first step in developing the intervention was to identify a standard podcast for testing. 
The research team selected the medication warfarin, as it has a narrow therapeutic index 
and  is a common source of serious drug interactions and adverse events.
24
 The research 
team, identified that the original AudibleRx
TM
 warfarin podcast was comprehensive but 
contained complex terminology and medical jargon such as “anticoagulation” and “atrial 
fibrillation”. The research team developed a health literacy guideline for audible 
medication information (Table 4.1), and used the guidelines to rewrite the AudibleRx
TM
 
script for individuals with lower health literacy. A professional voice actor from the 
website Voices.com was hired and asked to read the script while applying the health 
literacy guidelines for audio recording, which included adding introductory music, 
transition sounds and voice inflection to provide a better listening experience.  
Finally, after the podcast recording was complete, one NFC chip was programmed with 
the web address of the original podcast and a second NFC chip was programmed with the 
web address of the health literacy podcast. Each NFC chip was affixed to a standard 
warfarin medication vial. A Quick Response (QR) code was also affixed to the 
medication vial label as an alternative method for accessing podcasts. 
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Table  4.1: Health literacy guidelines for audible medication information                   
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4.2.2.Population sample 
 
The population sample used in the feasibility study included adults over age 40 and who 
had used at least one prescription medication for a chronic disease within the last three 
months. Participants were excluded if they did not speak any English or if they had used 
warfarin in the past. Participants were recruited using purposive sampling to ensure that 
the sample population contained individuals likely to experience lower health literacy, 
including seniors, ethnic/racial minorities, and people with low income and with low 
education. Health literacy levels were determined using the Short-Test of Functional 
Health literacy (STOFHLA).
25
 
4.2.3. Recruitment 
 
Participants were recruited from the Kitchener-Waterloo area and the Greater Toronto 
region through seniors programs, English as a Second Language (ESL) programs, 
libraries and retirement homes. Participants were recruited using a study poster and 
verbal script, which invited participants take part in a 50-minute study comparing current 
pharmacy information to new audible medication information technology. Participants 
were given a $10 (CAD) for their involvement in the study.  
4.2.4. Standard pharmacy care 
 
After preliminary data was collected, all participants were provided with standard 
pharmacy care that consisted of pharmacy counseling and a patient handout on warfarin. 
The intention was to mimic standard pharmacy care provided to individuals with a new 
warfarin prescription. To develop the standard counseling statement, three pharmacists at 
different locations were randomly identified and asked to share the information they 
would disclose to a patient with a new warfarin prescription. The five statements were 
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collated and used to prepare a standard statement that could be read to all patients. The 
final statement was reviewed by two additional community pharmacists. None of the 
pharmacists had a previous relationship with the research team. To simulate new use, 
participants were told, 
“Picture yourself as a patient newly diagnosed with an irregular heartbeat by 
your physician. Imagine you have just come from the physician’s office and now 
are headed toward the pharmacy to fill your prescription. The physician has 
prescribed a new medication called warfarin to prevent a stroke. You hand your 
prescription to the pharmacist who responds: “The medication prescribed by 
your doctor is called warfarin, a blood thinner that you use once a day. You will 
need regular blood work to make sure your blood isn’t too thin and you will also 
need to monitor for any signs of bleeding. Please warn your doctor if you see any 
signs of bleeding. For more information, there is a medication information sheet 
inside your prescription bag. Have a great day.” 
4.2.5. Testing of the Intervention 
 
Figure 4.2 outlines the study flow. The study took place in a private area within each site, 
to ensure information was kept confidential. The study began with each participant 
completing a demographic characteristics questionnaire, which included sex, education, 
age, ethnicity and income. 
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Figure 4.2: Study design flow chart  
 
The interviewer read the standard pharmacy care counseling statement to the participant 
and then provided the patient handout for warfarin. Participants were asked to use the 
patient handout as they would at home. When participants indicated they were done with 
the patient handout, a medication knowledge test was given to determine the knowledge 
they obtained from standard pharmacy care. To create a washout period before 
intervention, participants were given the 7-minute STOFHLA to assess health literacy 
levels.  
The sample population was randomized using an online randomization website 
(https://www.randomizer.org/). Participants were randomized into two different 
intervention groups: 1) standard AudibleRx
TM
 podcast, and 2) low health literacy 
AudibleRx
TM
 podcast. Participants were asked to imagine they were back at the 
pharmacy where the pharmacist has just finished counseling them on their new 
prescription for warfarin. This time, the pharmacist has ended the counseling session by 
stating the following: 
“For more information, there is reliable and simple information that you can 
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accessibly listen to on demand by simply tapping over your medication bottle to 
your phone or tablet.  There is also a medication information sheet inside your 
prescription bag.  Have a great day.” 
Participants were then provided with a smartphone that they could tap to the medication 
bottle to hear either podcast #1 or #2. Following the intervention, the medication 
knowledge test was re-administered with the questions in a different order to assess the 
participant’s medication knowledge. Finally, participants were given a user experience 
questionnaire on their experience with the NFC-chip enabled podcast. 
4.2.6. Outcome measures 
 
The primary outcome measure was the number of correct answers the participants scored 
on the knowledge assessment with standard care, standard AudibleRx
TM
 podcast and low 
health literacy AudibleRx
TM
 podcast.  A secondary outcome measure was the change in 
correct answers on the knowledge assessment at pre-intervention to post-intervention in 
the control and intervention groups. Another secondary measure was the participant's 
stated user experience.  
4.2.7. Data analysis  
 
Data were analyzed using the statistical analysis program, SPSS 22 (IBM Corp. Released 
2013. IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp.) . 
Additionally, demographic characteristics, which included STOFHLA score, were 
compared using Pearson Chi square tests in both intervention groups. Interventions and 
standard pharmacy care were compared using standard one-sided and paired t-tests. A 
one way ANOVA was also used to find any significant difference between health literacy 
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levels and test scores in both standard and treatment groups. All results were considered 
statistically significant if the p-value was less than 0.05. 
4.3. Results 
 
4.3.1. Demographic characteristics  
 
There were 30 participants who had a mean age of 59 years old and ranged in age from 
40 to 70 years old (Table 4.2). The sample consisted of  66.7% female and 33.3% male 
participants, where 93.4% had an education below high school and 36.7% had an 
education below grade eight. Participant backgrounds included South Asian (33.3%), 
European (23.3%), East Asian (13.3%), East African (10%), Middle Eastern (10%), Latin 
American (3%) and Canadian (3%). Additionally, 40% of participants reported an 
income of less than $10,000 (CAD) per year. According to the STOFHLA, 56.7% of 
participants had low health literacy, 23.3% had moderate health literacy and 20% had 
adequate health literacy. Income and education was significantly associated with low 
health literacy but age, gender and ethnicity were not (Table 4.2). There was no 
significant difference between the demographics of participants in intervention 1 and 
intervention 2.  
4.3.2. Medication Knowledge Test Scores 
 
After all 30 participants were given standard pharmacy care, the overall mean score for 
the first knowledge test was 6.10/16 (38%) (Table 4.3). After the intervention, the overall 
mean score on the knowledge test for the standard and health literacy podcasts were 
12.03/16 (75%) and 12.80/16 (80%), respectively (Table 4.3). Both intervention podcasts 
performed significantly better than standard pharmacy care (p<0.001). However, the 
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mean improvement from test score 1 to test score 2 was 4.93/16 for the standard podcast 
and 7.73/16 for the health literacy podcast. Hence, results indicate that the health literacy 
podcast improved test scores more than the standard podcast (p <0.001). 
4.3.3. Health Literacy and Knowledge Test Scores 
 
After standard care, there significant difference between the test scores of different health 
literacy levels (p<0.001). Further analysis demonstrated that participants with low health 
literacy had a significantly lower test score than participants with marginal health literacy 
(p=0.005) and adequate health literacy (p=0.01). Specifically, participants with low 
health literacy scored 2.56 points less than participants with marginal health literacy, and 
3.11 points less than participants with high health literacy. However, there was no 
significant difference in test score in the health literacy groups after both intervention 
podcasts meaning the difference in test scores that were apparent with standard care no 
longer existed after a podcast (Table 4.4).  
4.3.4. AudibleRx Experience  
 
Participants from both of the AudibleRx
TM
 podcast versions described the intervention as 
a useful and effective method for understanding medication information. Participants also 
highlighted how the podcasts provided information that was not covered in pharmacist 
counseling and patient handouts, such as what do to when a dose is missed and the risks 
and benefits of not taking their medication. Additionally, for both versions of the 
AudibleRx
TM
 podcast, participants reported that they enjoyed listening to the information 
and 20/30 (66.7%) participants preferred the podcasts to patient handouts because of 
challenges with reading, such as reading slow and mispronouncing words. Participants 
shared how they understand verbal information more than written information and found 
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listening to information to be less time consuming and simpler. 
 Participants given the standard AudibleRx
TM 
podcast disliked the use of scientific jargon, 
the length, and found the information to be overwhelming. Participants reported that they 
would like to hear breaks in between podcast segments and for the speaker to be more 
engaging. By comparison, participants noted that the low health literacy AudibleRx
TM 
podcast made them feel they were listening to their own pharmacist. Additionally, 
participants liked the introductory overview of the medication at the start of the podcast 
because it helped them prepare for what they were about to hear. Participants also 
highlighted that the transition sounds between segments and that the repetition of 
important information helped them stay alert, pay attention and listen with more clarity.  
4.3.5. NFC and QR Code Preference 
 
After the intervention, participants were asked to try accessing the podcast through both 
the NFC tag and the QR code. All participants favored the NFC tag because it did not 
require an additional software download, it was fast and it was very simple to understand. 
On the other hand, participants had difficulties scanning the QR code and believed the 
QR code was slow compared to the NFC tag. Finally, 28/30 (93%) participants stated 
they would use NFC enabled AudibleRx
TM
 podcasts in the future and 25/30 (83%) 
participants stated they would use the QR code enabled AudibleRx
TM
 podcasts in the 
future. 
4.4. Discussion 
 
This feasibility study demonstrated that patients from all health literacy levels can benefit 
from an NFC-enabled AudibleRx
TM
 podcast. To our understanding, there has been no 
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study that explores the use of audio podcasting as an additional method of pharmacy 
counseling. The results of this study were also consistent with other research showing 
that lower income and education levels are closely tied to lower health literacy levels.
3 
In 
regards to medication knowledge, the AudibleRx
TM  
podcasts were successful in 
significantly improving the medication knowledge test scores of participants from all 
health literacy levels compared to standard pharmacy care. Although both AudibleRx
TM 
podcasts improved test scores, the low health literacy AudibleRx
TM 
podcast version had 
an additional significant improvement compared to the standard AudibleRx
TM 
podcast.
 
The low health literacy AudibleRx
TM
 podcast in which we modified the content by 
mapping the script, simplifying the language, and repeating and summarizing 
information,
 
was seen by participants as desirable, engaging and enjoyable.  
One interesting finding was that there was a significant difference between health literacy 
levels and standard care test scores, where participants with lower health literacy had 
significantly lower test scores than participants with marginal and adequate health 
literacy. The differences between standard care test scores are a good reminder that 
pharmacy patients with low health literacy struggle more than patients with higher health 
literacy.  
In this study, after participants were given the AudibleRx
TM 
podcast interventions, there 
was no difference between health literacy levels and test scores, which demonstrates that 
AudibleRx
TM 
podcasts may have tackled barriers and challenges individuals with low 
health literacy face. As described in chapter 3, people with low health literacy report that 
they have a variety of challenges with current medication information such as difficulty 
reading, understanding, and remembering medication information. Therefore, we cannot 
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overestimate the importance of low health literacy interventions for pharmacy patients 
such as the AudibleRx
TM
 podcasts. 
Previous novel interventions similar to AudibleRx
TM 
such as the audio booklet for statin 
therapy 
26
 and electronic blister packs.
27
 The audio booklet combined audio medication 
information with pictographs that covered basic information about cholesterol and how 
statin medications work.
26
 Although the audio booklet improved patient knowledge, the 
format meant that patients could only access the audio booklet at the physician visit.
26 
By 
comparison, the electronic blister pack aimed to improve medication adherence by 
detecting medication non-adherence through  radio-frequency identification (RFID) 
technology and sending a text message reminder to participants when a medication was 
not taken. 
27
 However, the electronic blister packs only improved medication adherence 
for an average of one out of the four medications.
27 
4.1.1. Future studies 
 
Although NFC tags were desired more than QR codes, future research with more focus 
on QR codes should be conducted. Implementing QR codes into pharmacy practice is 
simpler because QR codes can be printed on a medication label. AudibleRx
TM
 podcasts 
could also be easily shared through email, social media, and on pharmacy websites. 
Future studies should also apply health literacy guidelines for medication information 
developed in this study as a method to develop information that will benefit all 
individuals, rather than focusing on higher literacy patients. 
 
 Pharmacy stakeholders and policy makers should consider implementing podcast 
interventions such as AudibleRx
TM 
 into pharmacy standard care to improve medication 
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knowledge across all patients, regardless of health literacy levels. Therefore, this 
feasibility study demonstrates that a full-scale pragmatic randomized control trial study in 
the pharmacy can be conducted. Future studies on interventions such as this would 
include testing more than one drug, including participants who were newly prescribed a 
medication and measuring long-term medication adherence and health outcomes. Future 
studies could also include a usual care group that continues to receive the standard care 
throughout the study, demonstrating the effect of general pharmacy information over the 
longterm. A full-scale study would provide further evidence of the effect of 
implementing NFC- or QR-code enabled AudibleRx
TM
 podcasts as an additional tool for 
pharmacy counseling.  
4.1.2. Limitations   
There are four main limitations in this study. The first is that the study targeted older 
adults, many of whom spoke English as an alternate language, which may limit the 
generalizability of the study results to populations who have low health literacy primarily 
due to education or economic variables other than ethnicity/race. The second limitation is 
that there is no current standardized assessment for health literacy, but of the available 
assessments, the STOFHLA is regarded as the most acceptable and commonly used tool 
for determining health literacy. The third limitation is that there was the risk of 
instrumentation bias as we used the same knowledge test both before and after. Though 
we did include a seven minute washout period using the STOFHLA, we recognize that it 
may not have been enough time to completely address this bias. Finally, the fourth 
limitation is that we recruited theoretical patients who were to imagine they had been 
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newly prescribed warfarin, which means they may not have been as motivated to learn as 
actual warfarin patients.  
4.5. Conclusions 
 
The NFC-enabled AudibleRx
TM
 podcasts significantly improved medication knowledge 
in participants with low, marginal and adequate health literacy, especially when written 
for a low health literacy population. If patients are given reliable, comprehensive, and 
simple information about a medication through an intervention such as AudibleRx
TM
, 
which they can accessibly listen to on demand, the patient should have sufficient 
understanding of their medication to properly follow instructions and self-manage their 
medications. Interventions such as AudibleRx
TM 
are an important step towards supporting 
low health literacy patients in becoming more confident and taking steps toward 
understand their medication, adhering to their medication and feeling comfortable 
discussing their medication with health professionals. 
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Table 4.2: Demographic characteristics of sample (N=30) 
 
Variables Intervention 1 
(n=15) 
Intervention 2 
(n=15) 
Difference 
between 
groups 
 
Age 
40-49 
50-59 
60-64 
65+ 
 
1 
6 
3 
5 
 
3 
7 
1 
4 
 
0.728 
 
Gender 
Male 
Female 
 
4 
11 
 
5 
10 
 
0.475 
 
Ethnicity 
European 
South Asian 
East Asian 
East Africa 
Middle Eastern 
Latin American 
Canadian 
 
4 
4 
2 
1 
1 
2 
1 
 
 
3 
6 
2 
2 
2 
0 
0 
 
0.075 
 
Income 
<$10,000 
$15,000-24,000 
$25,000-34,000 
$35,000-49,000 
     >$50,000 
 
6 
1 
5 
3 
0 
 
6 
3 
4 
0 
2 
 
0.794 
 
Education 
<Grade 8 
Grade 9-11 
Completed high 
school 
College/University 
 
6 
3 
4 
2 
 
5 
3 
4 
3 
 
0.781  
Health literacy score 
Low 
Moderate 
Adequate 
 
7 
4 
4 
 
10 
3 
2 
0.606  
N/A= not applicable
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Table 4.3: Test score differences between intervention 1 and intervention 2 (N=30) 
 
 Mean 
score 
N Mean 
difference 
SD CI(95%) p-
value 
 
 
 
Intervention 1 
(n=15) 
 
 
 
Standard 
care test 
score 
 
 
6.40/16 
 
15 
 
 
-4.86 
 
2.03 
 
-5.99,-3.72 
 
.001 
 
 
 
 
Treatment 
test score 
 
11.27/16 
Intervention 2 
(n=15) 
 
Standard 
care test 
score 
 
 
5.80/16 
 
15 
 
-7.00 
 
2.36 
 
-8.30,-5`.69 
 
.001 
 
Treatment 
test score 
 
12.8/16 
 
 
Table 4.4: Test score differences between health literacy levels 
 
ANOVA Bonferroni Post Hoc Test 
 Df F p-value Health literacy level Mean 
difference 
Std. 
Error 
p-
value 
 
Standard 
care test 
score 
 
Between 
groups 
 
Within 
groups 
 
Total 
 
 
2 
 
 
27 
 
 
29 
 
11.18 
 
0.000 
 
low 
 
low 
 
moderate 
 
 
moderate 
 
adequate 
 
adequate 
 
 
 
-2.56 
 
-3.11 
 
-.571 
 
 
 
0.731 
 
0.773 
 
0.905 
 
 
 
 
0.005 
 
0.01 
 
1.00 
 
 
 
Intervention 
test score 
 
 
 
 
 
 
Between 
groups 
 
Within 
groups 
 
Total 
 
2 
 
 
27 
 
 
29 
 
0.685 
 
0.513 
 
low 
 
low 
 
moderate 
 
 
 
 
 
 
moderate 
 
adequate 
 
adequate 
 
-1.04 
 
-1.30 
 
-.262 
 
 
 
 
1.22 
 
1.29 
 
1.51 
 
 
 
1.00 
 
0.969 
 
1.00 
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Chapter 5: Overall Discussion and Conclusions 
 
Half of North American adults use at least one prescription medication. Yet, many North 
American adults do not have the capacity to obtain, process and understand basic medication 
information, meaning they struggle to self-manage their health and make appropriate health 
decisions. In today’s busy pharmacies, medication information is presented at a tenth grade level, 
while huge swaths of the population can only read at a fifth-grade level. As described in the 
introductory chapter of this thesis, current medication information too difficult to understand, 
low health literate populations are at a higher risk of misinterpreting prescription label 
instructions, dosages, duration of therapy, frequency of dosing, warning labels, written 
information and verbal pharmacist counseling 
 
In the first section, I completed a systematic review to investigate the evidence on interventions 
that improve medication knowledge and adherence for low health literate populations. I found 
that interventions that targeted low health literate populations were a positive approach to 
improving patient’s medication knowledge and adherence. Effective interventions varied from 
providing patients with written information, verbal information, label information to reminder 
systems to educational program/services. The interventions targeted to low health literate 
populations that were effective generally aimed to remove specific barriers and challenges faced 
by low health literacy populations, by either giving more information that is simpler to 
understand, personalizing information or making information easier to use and more accessible. 
For example, interventions that involved translating medication information on a prescription 
label removed the challenge of reading and the barrier of language.  
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In second section, I outlined the low health literate population’s pharmacy experience with 
medication information and found four main challenges: not understanding medication 
information, forgetting to take medication, experiencing and dealing with side effects and 
managing food-drug instructions and interactions. I found that these challenges were faced due to 
certain barriers such as time, communication, memory and support from the pharmacy. When 
these challenges and barriers were experienced, the low health literate participants reported that 
they would seek help from pharmacists, physicians, family, and friends in their attempts to 
address their challenges. However when challenges were still present, low health literate 
populations are left with unanswered questions or concerns, which lead to their perception of 
negative medication related outcomes including adverse events, their need to assume 
instructions, their need to refer to unreliable sources of information, errors and apathy towards 
their treatment. There is a clear gap between the levels of skill required to understand current 
medication information and the actual level of understanding among low health literate 
population.  
 
Although there are a variety of interventions being tested to improve heath literacy in practice, 
none have been widely implemented. It may be possible health literacy interventions for 
medication information like PictureRx have not been implemented into pharmacy practice 
because it requires an increased workload for the pharmacy staff and requires a substantial 
amount of time and resources. One of the main challenges faced for pharmacists is the difficulty 
they face in identifying patients with low health literacy. Low health literacy becomes a more 
difficult problem when patients overestimate their health literacy levels because of the fear of 
being judged on not being able to read, write or understanding information and feeling ashamed 
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to seek clarification from the pharmacist. Therefore, interventions that provide a shame-free and 
blame-free environment and require minimal time and cost can be implemented into pharmacy 
practice.  
 
Therefore, in section three I developed and tested a low health literacy intervention with patients 
of mixed heath literacy. Mobile information and communication technologies have been 
emerging as a tool for patient education and may be a solution for providing interventions that 
can be easily adopted into a pharmacy practice. AudibleRx
TM
 is a pharmacist-managed website 
that aims to provide consumers with web and mobile medication information through audio 
podcasting. We tested an existing AudibleRx
TM  
podcast and a podcast that was modified using 
communication strategies for low literacy populations. Both versions of the podcast were 
successful in significantly improving the medication knowledge test scores of participants from 
all health literacy levels compared to current standard pharmacy care. However, the low health 
literacy AudibleRx
TM 
podcast version provided an additional significant improvement over the 
standard AudibleRx
TM 
and was also perceived as a more desirable, engaging and enjoyable, 
which suggests the benefit of applying health literacy guidelines.  The most important finding in 
the feasibility study was the significant difference between health literacy levels in standard care 
test scores, which demonstrated that low health literate participants scored poorer and were at a 
disadvantage with the current standard pharmacy care. Conversely, after the AudibleRx
TM 
podcast intervention, there was no difference between the health literacy levels and test scores, 
which demonstrates that AudibleRx
TM 
podcasts may have tackled barriers and challenges 
individuals with low health literacy face.  
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In conclusion, this thesis was an exploration of interventions to improve the experience of 
pharmacy patients who have low health literacy. The work herein highlights the importance of 
developing easy to implement tools that help low health literacy populations use, understand and 
explore medication therapy. This is an important step towards improving patient outcomes by 
reducing medication non-adherence and adverse event.  
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Student Investigator: Huda Wali (hwali@uwaterloo.ca) 
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A signed copy of the Notification of Full Ethics Clearance will be sent to the Principal 
Investigator or Faculty Supervisor in the case of student research. 
 
---------------------------------- 
Maureen Nummelin, Ph.D. 
Director, Office of Research Ethics 
519.888.4567 x 36005 
maureen.nummelin@uwaterloo.ca 
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Appendix 1.2.- Information letter  
 
Project: Exploring patient perceptions of drug-food interactions with adults over age 50. 
Organizers: Huda Wali (Student), Kelly Grindrod (Supervisor) 
 
INFORMATION LETTER & CONSENT 
2 January 2014 
Dear Potential Participant: 
This letter is an invitation to participate in a study being led by Ms. Huda Wali at the School of 
Pharmacy at the University of Waterloo to fulfill my academic requirements. We are asking you 
to participate in a twenty-minute interview where we will explore your thoughts on drug-food 
interactions. 
 
Study objectives 
Certain foods can interact with drug and affect how safe and effective the drugs are. Many 
people take a prescription drugs and may not know the risks or benefits some foods can pose. 
The effects depend on the type of drug and the type of food or drink being consumed. In one 
example, many drugs that are taken orally travel from the stomach to the liver, where specific 
enzymes break them down. Introducing a new substance before or even after you take a drug 
may affect how the drug is broken down by making the enzymes work faster or slowing them 
down. Other food-drug interactions are related to vitamins and minerals being consumed such as 
Vitamin K, calcium and iron. 
Current research has focused on investigating what foods or nutrients have interactions to certain 
drugs. Little research has been done to explore how we can assist an individuals understanding of 
food-drug interactions with their prescriptions. The purpose of this study is to explore the 
perceptions of food-drug interactions among people over age 50, particularly in individuals who 
speak English as an alternate language.  
 Our goal is to gather information to develop a targeted intervention designed to educate 
medication users about drug-food interactions by improving health literacy.  
Study overview 
If you agree to participate, you will be asked to join in a 30-minute interview at Northwood 
Neighborhood seniors program in Toronto, between January and March 2013. We will begin by 
asking you to share a little bit about yourself and any experiences in life you wish to share. We 
will then ask you to answer general questions about drugs such as your experience using 
prescription drugs, getting information from the pharmacy and any problems you have had or 
had to overcome with your prescriptions. Shortened Test of Functional Health Literacy 
Assessment (STOFHLA) will be used as a validated measure of health literacy (Ref. Baker DW, 
Williams MV, Parker RM, Gazmararian JA, Nurss J. Development of a brief test to 
measure functional health literacy. Patient Educ Couns. 1999;38:33-42.).This will assess 
 109 
 
your level of understanding of health-related information. A language interpreter will be present 
should you require translating assistance.  
Your participation is voluntary 
Participation in this study is voluntary. You may decline to answer any of the questions we ask if 
you so wish. Further, you may decide to withdraw from this study at any time without any 
negative consequences by advising the researcher.  
Risks 
We do not anticipate any risks to you due to participating in this study.  
Eligibility Requirements for Participation  
All participants must be adults aged 50 or over. Participants are not required to speak and read 
English; a interpreter will be present for assistance. Participants are welcome to join the research 
study regardless of their health care services.  
 
Confidentiality and Data Retention  
All information you provide will be considered confidential and de-identified, which will not be 
anonymous.  Your responses will be grouped with other participants and collected using paper 
forms and via audio recording of the interview discussions. A unique study identifier (e.g., ABC-
123) will be used in the place of your name on data collection forms 
 Although the interview discussion will be audio recorded, nothing that you or anyone else says 
during the interview will ever be associated with your name in any report or publication. Only 
participants who agree to be audio-recorded will be eligible to participate in the study. All of 
your comments will remain confidential and, if you need an interpreter, we will ask the 
interpreter to keep what you say during the interview in strict confidence. . If you choose to 
withdraw from the study at any point, your information will be destroyed. 
Even though the results may be used in reports or publications, only the research team will have 
access to your data from the evaluations. Data such as interview audio and written information 
will be stored in an encrypted and password protected file on an encrypted laptop kept in a 
locked office at the School of Pharmacy in Kitchener, Ontario for 25 years.  
Remuneration  
We will not be providing any payment to you for participating in this study but you will be 
served a hot meal on behalf of Northwood Neighborhood. 
Questions and Contact  
If you have any questions about participation, or would like additional information to assist you 
in reaching a decision about participation, please contact me: Huda Wali (647) 883-8304 or via 
email at hwali@uwaterloo.ca.  
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Ethics Review and Clearance  
I would like to assure you that this study has been reviewed by, and received ethics clearance 
through, the Office of Research Ethics at the University of Waterloo. However, the final decision 
about participation is yours. In the event you have any comments or concerns resulting from your 
participation in this study, please contact Dr. Maureen Nummelin, the Director, Office of 
Research Ethics, at 1-519-888-4567, Ext. 36005 or maureen.nummelin@uwaterloo.ca. 
We hope that the results of our study will be of benefit to those organizations directly involved in 
the study, other voluntary recreation organizations not directly involved in the study, as well as 
to the broader research community. 
Yours sincerely,  
 
Huda Wali, BSc 
Graduate Student  
School of Pharmacy 
University of Waterloo 
(647) 883- 8304 
hwali@uwaterloo.ca 
 
Kelly Grindrod, BScPharm, PharmD, MSc 
Assistant Professor 
School of Pharmacy 
University of Waterloo 
(519) 888-4567 x 21358 
kgrindrod@uwaterloo.ca  
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Appendix 1.3 Consent form 
 
CONSENT FORM – AGREEMENT TO PARTICIPATE 
By signing this consent form, you are not waiving your legal rights or releasing the 
investigator(s) or involved institution from their legal and professional responsibilities. 
I have read the information presented in the information letter about a study being conducted by 
Huda Wali of the School of Pharmacy at the University of Waterloo. I have had the opportunity 
to ask any questions related to this study, to receive satisfactory answers to my questions, and 
any additional details I wanted. 
I am aware that I have the option of allowing the interview to be audio recorded to ensure an 
accurate recording of my responses. Audio recording will not begin until participants have 
consented. If I do not wish to be audio recorded I will not be able to participate in study. 
I am aware a Shortened Test of Functional Health Literacy Assessment (STOFHLA) will be used 
as a validated measure of health literacy. 
I am also aware that excerpts from the interviews may be included in any reports and/or 
publications to come from this research, with the understanding that the quotations will be de-
identified.  
I am aware that interpreter s are chosen by Northwood Neighborhood from an accredited list and 
will also be asked to sign a confidentiality form.  
I was informed that I may withdraw my consent at any time without penalty by advising the 
researcher and all data and audio recording will be properly erased.  
This project has been reviewed by, and received ethics clearance through, the Office of Research 
Ethics at the University of Waterloo.  I was informed that if I have any comments or concerns 
resulting from my participation in this study, I may contact Dr. Maureen Nummelin, the 
Director, Office of Research Ethics, at 1-519-888-4567, Ext. 36005 or 
maureen.nummelin@uwaterloo.ca. 
With full knowledge of all foregoing, I agree, of my own free will, to participate in this 
study. 
YES     NO     
I agree to the audio recording of the focus group discussion. 
YES    NO     
I agree to the use of anonymous quotations in any report and/or publication that comes of 
this research. 
YES   NO 
Participant Name: ____________________________________________(Please print)   
Participant Signature: _________________________________________  
Date: ______________________________________ 
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Appendix 1.4- Adult interview script 
 
ADULT INTERVIEW SCRIPT 
 
When participants arrive at senior program 
 
If there’s an interpreter present, research or interpreter to introduce both parties and remind 
potential participants that the interpreter is available if needed. 
 
Researcher/Investigator: Thank you for agreeing to participate in this interview where we hope 
to get information to help us create a tool to educate people about drug-food interactions. Please 
take a seat and feel free to read about the project and fill out the consent forms if you decide you 
would like to participate.  
 
Researcher/Investigator [Introduce self and study investigators]: Before we get started, I would 
like to go over guidelines for the interview. During the interview, I will ask answers. The 
purpose of these interviews is to generate as many different ideas and opinions as possible.  
 
Turn on voice recorder 
 
Questions: 
  
Background questions 
 
Measuring Health Literacy 
On a scale from 1 to 5 how often do you have someone help you read materials about your 
medications? (1 rarely--> 5 very often) 
On a scale from 1 to 5 how confident are you filling out medical forms by yourself? (not 
confident--> confident) 
On a scale from 1 to 5 how often do you have problems learning about your medications because 
of difficulty understanding written information? (rarely-->very often) 
 
Research study questions 
 
Thinking of how you take your medication, can you take me through a typical day?   
 
What happens when you get a new prescription? 
 
 
Thinking of your medications, what challenges or troubles do you have taking your medication? 
 
Can you list the medications including the dose, directions you are currently on? 
 
What are you taking each one for? 
Can you show me your pill packs or bottles?  
If there are any labels on prescription bottle:  
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-Can you tell me what this label means?  
If there are any auxillary/warning labels:  
Can you tell me what this label means? 
Are these labels useful?  
 
7. Do you know if any of your medications are taken on an empty or full stomach . Or if the 
doctor or pharmacist gave you some special food instructions? 
 
8.    When thinking of medication do they include any over the counter medication, vitamins or 
natural products?  
 
9.   What challenges do you face with these medications?  
 
10.  Can you tell me a general description of the foods and drinks you eat, specifically if taking: 
        Alcohol (each day/week/month) 
        Fruits and veggies (generally what/how often) 
                Green leafy veggies such as kale, cabbage, brussel sprouts, spinach 
                Potassium containing fruits such as bananas 
                Grapefruit or grapefruit juice 
        Dairy products including milk, cheese, yogurt, ice cream, calcium-fortified orange juice/soy 
milk etc 
 
11.  Has a pharmacist ever told you to wait to consume or avoid a certain food or drink when 
taking a medication?  
 
12.  Do you think you had enough information to decide what to eat or when to eat it? 
 
13.  When you eat or drink something, anything, how often do you think about its effects on your 
medication? Why?  
 
14. Is there anything else you would like to share with me? 
 
15. If we build a tool in the future, would you be interested in trying it out for us? 
 
General information 
 
What is your age? 
What is your gender? 
What is your language you speak most often? 
What is your highest level of education? 
When did you begin speaking English? 
Do you use a computer, tablet, smartphone 
Where?  
 
 
Researcher/Investigator: Provide a summary of the findings generated via the interview. 
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Turn off voice recorder 
 
Researcher/Investigator:  Thank you all again for participating. Your input is vital to our 
understanding of the usability of mobile medical apps for adults.  
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Appendix 1.5- Feedback letter 
 
Organizer: Huda Wali 
FEEDBACK LETTER 
Dear Participants, 
I would like to thank you for your participation in the study entitled “Exploring patient 
perceptions of drug-food interactions with adults over age 50.” As a reminder, the purpose of this 
project is to gather information to develop a tool to educate people about drug-food interactions.  
Please remember that information from the interview will be kept confidential. Once all of the 
data are collected and analyzed for this project, we plan on sharing this information with the 
research community through seminars, conference presentations and journal articles. If you are 
interested in receiving more information regarding the results of this research, or would like a 
summary of the results, please provide your e-mail address to the researchers. When the study is 
completed, anticipated by September 2015, we will send you the information. 
In the meantime, if you have any questions about the study, please do not hesitate to contact 
Huda Wali by e-mail or telephone, as noted below. As with all University of Waterloo projects 
involving human participants, this project was reviewed by, and received ethics clearance 
through, the Office of Research Ethics at the University of Waterloo. Should you have any 
comments or concerns resulting from your participation in this study, please contact Dr. Maureen 
Nummelin, the Director, Office of Research Ethics, at 1-519-888-4567, Ext 36005 or 
maureen.nummelin@uwaterloo.ca.  
Yours sincerely, 
 
 
 
 
Huda Wali, BSc 
Graduate Student  
School of Pharmacy 
University of Waterloo 
(647) 883- 8304 
hwali@uwaterloo.ca 
 
 
Kelly Grindrod, BScPharm, PharmD, MSc 
Assistant Professor 
School of Pharmacy 
University of Waterloo 
(519) 888-4567 x 21358 
kgrindrod@uwaterloo.ca  
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Appendix 2.0- The future of pharmacy counseling: AudibleRx and the application of health 
literacy guidelines 
 
Title: Health literacy guidelines to improving audible information   
ORE #: 20525 
Faculty Supervisor: Kelly Grindrod (kelly.grindrod@uwaterloo.ca) 
Student Investigator: Huda Wali (hwali@uwaterloo.ca) 
 
have been reviewed and are considered acceptable.  As a result, your application now has 
received full ethics clearance.  
 
A signed copy of the Notification of Full Ethics Clearance will be sent to the Principal 
Investigator or Faculty Supervisor in the case of student research. 
 
Maureen Nummelin, Ph.D. 
Director, Office of Research Ethics 
519.888.4567 x 36005 
maureen.nummelin@uwaterloo.ca 
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2.1. Participant recruitment script 
Researcher: 
Hello, my name is Huda Wali. I’m a graduate student at the University of Waterloo School of 
Pharmacy and I am currently working on a study to improve medication information, specifically 
focusing on audile medication information. Currently medication information is written in a 
complex manner that may increase the risk of misinterpreting prescription label instructions, 
dosage, duration, frequency, warning labels, written information and verbal pharmacist 
counseling. 
 
Health literacy is barrier to accurately understanding medication information because of the 
complex language required to understand current medication information. Low health literacy is 
defined as having an inadequate ability to obtain, read, understand and use health information to 
make appropriate health decisions and to follow proper instructions for treatment  
 
The purpose of this study is to provide participants with a new innovative technology called 
AudibleRx that provides reliable, comprehensive and simple information about a medication so 
that they can accessibly listen to on demand. This will allow patients to have sufficient 
understanding of their medication to properly follow instructions and self-manage their health. 
Our goal is to gather information on the improvement in knowledge and user experience with the 
AudbileRx, to determine the effectiveness and usability 
 
Participants attending senior program: Yes/No 
  
Researcher 
[If participants attending senior program]: Great, you will be asked to join in a fifty-minute 
interview at your retirement home/ senior program, between March and May 2015. We will 
begin with a screening assessment to determine if you are eligible to participate in this study by 
asking you to complete a Shortened Test of Functional Health Literacy Assessment (STOFHLA) 
to assess your level of understanding of health-related information and the Montreal Cognitive 
Assessment (MoCA) to assess cognitive levels. You will then by given a touch-screen tablet 
device where you will listen to the AudibleRx podcast. After listening to the audible podcast 
information, we will then ask you to complete a knowledge test about the medication and also 
your user experience with the AudibleRx podcast. 
 
This study has been reviewed and received ethics clearance through a University of Waterloo 
Research Ethics Committee. 
However, the final decision about participation is yours. Does this interest you at all? 
 
 [If yes, researcher to provide a copy of the information/consent form to read and sign before the 
researcher may advertise in the institution] 
  
OR 
  
 [If participants attending senior program does not agree]: Okay, I understand 
Researcher:  
Thank you for your time. 
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2.2. Information letter & consent form 
 
Dear Potential Participant: 
This letter is an invitation to participate in a study being led by Ms. Huda Wali at the School of 
Pharmacy at the University of Waterloo to fulfill Huda Wali’s Master thesis. We are asking you 
to participate in a fifty-minute interview where we will explore your thoughts on medication 
information you can listen to. 
 
Study objectives 
Health literacy is barrier to accurately understanding medication information because of the 
complex language required to understand current medication information. Low health literacy is 
defined as having an inadequate ability to obtain, read, understand and use health information to 
make appropriate health decisions and to follow proper instructions for treatment. Unfortunately, 
current medication information is written in a complex manner that may increase the risk of 
misinterpreting prescription label instructions, dosage, duration, frequency, warning labels, 
written information and verbal pharmacist counseling.  
 
The purpose of this study is to provide participants with a new innovative technology for called 
AudibleRx that provides reliable, comprehensive and simple information about a medication so 
that they can accessibly listen to on demand. This will allow patients to have sufficient 
understanding of their medication to properly follow instructions and self-manage their health. 
Our goal is to gather information on the improvement in knowledge and user experience with the 
AudbileRx to determine the effectiveness and usability. 
 
Study overview 
If you agree to participate, you will be asked to participate in a 50-minute audio-recorded 
interview. Before you enter the study, participants will need to able to speak English and read 
English to some degree and will also be required to complete a series of screening tests to assess 
if you qualified for the study. The screening tests will include a Shortened Test of Functional 
Health Literacy Assessment (STOFHLA) to assess your level of understanding of health-related 
information and the Montreal Cognitive Assessment (MoCA) to assess memory levels. You will 
then by given a touch-screen tablet device where you will listen to the AudibleRx podcast. After 
listening to the audible podcast information, we will then ask you to complete a knowledge test 
about the medication and also your user experience with the AudibleRx podcast. 
 
 
Your participation is voluntary 
Participation in this study is voluntary. You may decline to answer any of the questions we ask if 
you so wish. Further, you may decide to withdraw from this study at any time without any 
negative consequences by advising the researcher.  
 
Risks 
We do not anticipate any risks to you due to participating in this study.  
 
Eligibility Requirements for Participation  
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All participants must be adults aged 50 or over, who have used at least 1 prescription medication 
for a chronic disease within the last 3 months and who have not been on Warfarin.  
 
Confidentiality and Data Retention  
All information you provide will be considered confidential and de-identified.  Your responses 
will be grouped with other participants and collected using paper forms and via audio recording 
of the interview discussions. A unique study identifier (e.g., ABC-123) will be used in the place 
of your name on data collection forms 
 Although the interview discussion will be audio recorded, nothing that you or anyone else says 
during the interview will ever be associated with your name in any report or publication. Only 
participants who agree to be audio-recorded will be eligible to participate in the study. The 
interviews will be recorded to gather patient experience that will be used for research data.   All 
of your comments will remain confidential. If you choose to withdraw from the study at any 
point, your information will be destroyed. 
Even though the results may be used in reports or publications, only the research team will have 
access to your data. Data such as interview audio and written information will be stored in an 
encrypted and password protected file on an encrypted laptop kept in a locked office at the 
School of Pharmacy in Kitchener, Ontario for 7 years.  
 
Questions and Contact  
If you have any questions about participation, or would like additional information to assist you 
in reaching a decision about participation, please contact me: Huda Wali (647) 883-8304 or via 
email at hwali@uwaterloo.ca.  
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Ethics Review and Clearance  
I would like to assure you that this study has been reviewed by, and received ethics clearance 
through a University of Waterloo Research Ethics Committee. 
. However, the final decision about participation is yours. In the event you have any comments or 
concerns resulting from your participation in this study, please contact Dr. Maureen Nummelin, 
the Director, Office of Research Ethics, at 1-519-888-4567, Ext. 36005 or 
maureen.nummelin@uwaterloo.ca. 
We hope that the results of our study will be of benefit to organizations  involved in the 
developing medication information, as well as individuals who take medication. 
Yours sincerely,  
 
Huda Wali, BSc 
Graduate Student  
School of Pharmacy 
University of Waterloo 
(647) 883- 8304 
hwali@uwaterloo.ca 
 
Kelly Grindrod, BScPharm, PharmD, MSc 
Assistant Professor 
School of Pharmacy 
University of Waterloo 
(519) 888-4567 x 21358 
kgrindrod@uwaterloo.ca  
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By signing this consent form, you are not waiving your legal rights or releasing the 
investigator(s) or involved institution from their legal and professional responsibilities. 
I have read the information presented in the information letter about a study being conducted by 
Huda Wali of the School of Pharmacy at the University of Waterloo. I have had the opportunity 
to ask any questions related to this study, to receive satisfactory answers to my questions, and 
any additional details I wanted. 
 
I am aware that I have the option of allowing the interview to be audio recorded to ensure an 
accurate recording of my responses. Audio recording will not begin until participants have 
consented. If I do not wish to be audio recorded I will not be able to participate in study. 
 
I am also aware that excerpts from the interviews may be included in any reports and/or 
publications to come from this research, with the understanding that the quotations will be de-
identified. With your permission quotations may be used from the interview, however your name 
will not appear in any thesis or report resulting from this study.  
 
I was informed that I may withdraw my consent at any time without penalty by advising the 
researcher and all data and audio recording will be confidentially erased.  
This project has been reviewed by, and received ethics clearance through a University of 
Waterloo Research Ethics Committee was informed that if I have any comments or concerns 
resulting from my participation in this study, I may contact Dr. Maureen Nummelin, the 
Director, Office of Research Ethics, at 1-519-888-4567, Ext. 36005 or 
maureen.nummelin@uwaterloo.ca. 
 
With full knowledge of all foregoing, I agree, of my own free will, to participate in this 
study. 
YES     NO     
I agree to the audio recording of the interview. 
YES    NO     
I agree to the use of anonymous quotations in any report and/or publication that comes of 
this research. 
YES   NO 
Participant Name: ____________________________________________(Please print)   
Participant Signature: _________________________________________  
Date: ______________________________________ 
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2.3. Feedback letter 
Dear Participants, 
I would like to thank you for your participation in the study entitled “Health literacy guidelines 
to improving audible information.” As a reminder, the purpose of this project is to gather 
information to determine the effectiveness and preference for the AudibleRx intervention, a tool 
to educate people about prescription medications.  
Please remember that information from the interview will be kept confidential. Once all of the 
data are collected and analyzed for this project, we plan on sharing this information with the 
research community through seminars, conference presentations and journal articles. If you are 
interested in receiving more information regarding the results of this research, or would like a 
summary of the results, please provide your e-mail address to the researchers. When the study is 
completed, anticipated by September 2015, we will send you the information. 
In the meantime, if you have any questions about the study, please do not hesitate to contact 
Huda Wali by e-mail or telephone, as noted below. As with all University of Waterloo projects 
involving human participants, this project was reviewed by, and received ethics clearance 
through, the Office of Research Ethics at the University of Waterloo. Should you have any 
comments or concerns resulting from your participation in this study, please contact Dr. Maureen 
Nummelin, the Director, Office of Research Ethics, at 1-519-888-4567, Ext 36005 or 
maureen.nummelin@uwaterloo.ca.  
Yours sincerely, 
 
 
 
 
 
Huda Wali, BSc 
Graduate Student  
School of Pharmacy 
University of Waterloo 
(647) 883- 8304 
hwali@uwaterloo.ca 
 
 
Kelly Grindrod, BScPharm, PharmD, MSc 
Assistant Professor 
School of Pharmacy 
University of Waterloo 
(519) 888-4567 x 21358 
kgrindrod@uwaterloo.ca  
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2.4.Standard AudibleRx podcast script 
 
Warfarin (Coumadin) 
Warfarin is an anticoagulant medication that is used to treat blood clots and prevent new clots 
from forming in your circulatory system.  Warfarin works by limiting the specific event that 
produces functional vitamin K in the liver.  Vitamin K is necessary for the formation of clotting 
factors.   By limiting Vitamin K production and therefore decreasing the formation of clotting 
factors, warfarin is able to treat and prevent the formation of blood clots.   
 
Specific conditions pose an increased risk for developing a blood clot, such as irregular heart 
rhythm, a recent heart attack, heart valve replacement, and certain surgeries such as hip or knee 
replacement.   Blood clots form when there has been damage to the blood vessel, either the artery 
or the vein, and also when blood stops moving and becomes stagnant. 
 
An artery blood clot may occur when someone has developed plaque along the inside of the 
blood vessel from increased cholesterol, called atherosclerosis. The plaque increase and limits 
the space the blood has to flow.  If the plaque ruptures then a blood clot may form and lead to a 
stroke or a heart attack. 
 
A blood clot in the vein may occur when a person is immobilized for some reason and their 
muscles are not contracting to push the blood back to their heart.  Small clots begin to form in 
the stagnant blood along the walls of the vein.  These clots increase and eventually limit the 
amount of blood that returns to the heart.   
 
A blood clot may form in the heart when the heart is not beating in an organized fashion.  When 
the heart has irregular rhythm, blood tends to pool or stagnate in certain sections.  When the 
blood stagnates, little clots may form on inside wall of the heart.  These clots may then be 
pumped out into the circulatory system and lead to a stroke or a heart attack. 
 
Warfarin has a Black Box Warning.   Warfarin can cause major and even fatal bleeding.  This is 
more likely to happen during the starting/titration period, or when you have other ongoing 
disease states, or when warfarin is taken with other medications.  Your doctor will monitor your 
INR (bleeding time) very closely, especially during the startup period.  ...done with BBW and on 
with the session. 
 
Warfarin is usually taken once daily, with or without food.  It is important to take warfarin at the 
same time each day.  Your dosage of warfarin is based on your specific medical condition, your 
response to therapy and your INR results (your bleeding time results).  If you miss a dose of this 
medication, please take it as soon as you remember.  If it is near the time of your next dose than 
just skip it and continue with your normal dose time.  Please do not take a double dose to make 
up the missed dose.   
 
Warfarin is available from 2 or 3 different generic manufacturers.  The FDA has approved 
generic warfarin and it is an acceptable product.  Once your are stable on your dose of warfarin, 
it is a good idea to continue with the same generic brand so there are not any changes in the 
absorption characteristics of the medication.  Please, ask your pharmacist if they always maintain 
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the same brand of warfarin on their shelf, and definitely talk with your pharmacist before taking 
your warfarin if the pills look different than they looked last time. 
 
Your doctor may refer you to the local Anticoagulation Clinic for follow-up monitoring.  If your 
doctor does not bring this up, ask them about it.  An Anticoagulation Clinic is usually staffed by 
a Pharmacist or a Nurse.  They will have a protocol in place so that they may check your INR 
(your bleeding time) with just a finger stick and then adjust your warfarin dose if necessary.   
The goal of the anticoagulation clinic is to educate you about your anticoagulation medication, 
monitor your bleeding time and help prevent you from having an adverse event that leads you to 
the emergency room. 
 
If you are not involved in an anticoagulation clinic, than your doctor will have you go to a lab 
where they draw blood from your vein.  They will then check the INR in their lab and send the 
information to your doctor.  Your doctor will then call you and adjust your dose as necessary. 
 
Make sure you let your pharmacist or doctor know of all your medication allergies so they may 
determine if warfarin is safe for you to take. 
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2.5 Low health literate AudibleRx podcast medication script  
 
Welcome to AudibleRx.  
AudibleRx is here to provide you with simple, reliable information about your medication that 
you can listen to on demand. We hope to help educate you about your medication so you can 
confidently mange it. 
My name is Steve and I am a licensed pharmacist here to share information on your medication, 
Warfarin, also known as Coumadin.  
The purpose of this podcast is to help you understand: 
-What warfarin is  
-How to take warfarin safely 
- And why it is important to take warfarin.  
We also want you to understand: 
- How to monitor the effect of warfarin  
- The consequences of not taking Warfarin  
-And review some of its side effects. 
Lets begin learning about Warfarin. 
 
What is Warfarin and how does it work? 
Warfarin is an anticoagulant medication, which means it reduces the formation of blood clots. 
Warfarin is used to prevent heart attacks, strokes and to treat blood clots in the veins and arteries. 
Warfarin works by limiting blood clots forming by blocking vitamin K. Vitamin K is needed to 
form blood-clotting factors. By blocking vitamin K, we can stop and limit the blood clots from 
forming. Warfarin can also prevent existing clots from getting bigger.  
 
The key point here is, warfarin limits vitamin K clotting factors and decreases the body’s ability 
to form blood clots.  
Blood clots form when there has been damage to the blood vessel, either the artery or the vein, 
and also when blood stops moving in the body. 
You may be at a higher risk of developing blood clots if you have any of the following four 
conditions: 
1) Irregular heart rhythm 
2) A recent heart attack 
3) Heart valve replacement 
4) Certain surgeries such as hip or knee replacement 
 
The key point is, if you do not take your medication, you are at a higher risk of forming blood 
clots. If you do not take warfarin, blood clots can form and cause a stroke or heart attack.  
 
How to take Warfarin? 
Warfarin is usually taken once daily, with or without food.  It is important to take warfarin at the 
same time each day.  Your dosage of warfarin is based on your specific medical condition and 
your response to warfarin. Your response to warfarin is determined by what is called your 
"international normalized ratio" (INR for short), which is your bleeding time result. If you miss a 
dose of this medication, please take it as soon as you remember.  If it is near the time of your 
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next dose then do not double up your dose, skip the dose you missed and wait for your normal 
time of dosing to then take your normal dose.  
 
How do I know if the medication is working? 
Your doctor will check your international normalized ratio (the INR), to help ensure your dose is 
right for you and to prevent any negative effect of the drug. For this purpose, your doctor may 
refer you to the local Anticoagulant Clinic to monitor the effect of the drug on your body. At the 
anticoagulant clinic, they will check your INR, the bleeding time, and will help educate you on 
your medication.  
In case you are not involved in an anticoagulation clinic, your doctor will have you go to a lab, 
where they will take your blood and check the INR in their lab. The lab report will then be sent 
to the doctor to change your dose as needed. 
 
What are the side effects? 
Warfarin has a Black Box Warning. A Black Box warning is an alert to warn patients of any 
potentially severe side effect. Warfarin’s Black Box side effect is that it can cause major and 
even life-threatening bleeding. Major Bleeding is more likely to happen during the starting 
period of medication or if you have other current diseases. To reduce your risk, your doctor will 
monitor your bleeding time very closely, especially as you start taking Warfarin.   
Be sure to let your pharmacist or doctor know about all the medications you are taking, including 
over the counter supplements, even if you only take them sometimes.  Your pharmacist will be 
happy to check to see if what you are taking is safe to take with warfarin.   
You may experience some minor side effects when taking warfarin. You may experience nausea, 
loss of appetite and may have a tendency to bleed easily.  If you notice any unusual bleeding, 
such as bleeding from the gums while brushing your teeth, a constant nosebleed, or long 
bleeding from a cut, you should report this to your doctor.   
 
The key point to remember is everyone who takes warfarin will experience side effects; 
however, if you notice any concerning side effects, talk to your doctor or pharmacist.  
Warfarin is not recommended for use during pregnancy because of the potential for serious harm 
to the unborn baby.  If you are of childbearing age, discuss with your doctor the best option for 
you to keep from becoming pregnant while you take warfarin.  Likewise, consult your doctor 
before breast-feeding while you take warfarin.   
 
What is a generic medication?  
Sometimes your pharmacy will give you the generic brand name of your medication, if you have 
concerns about the differences, talk to your pharmacist.  
A generic medication is drug product that is comparable to the brand name drug. The Food and 
Drug Administration, the FDA, has approved generic warfarin, which is the same drug but a 
different brand. Warfarin is available from 2 or 3 different generic manufacturers. Once you are 
consistent with your dose of warfarin, it is a good idea to continue with the same generic brand. 
Please, ask your pharmacist if they always maintain the same brand of warfarin on their shelf, 
and talk with your pharmacist before taking your warfarin if the pills look different than they 
looked last time you filled your prescription. 
 
Here are some everyday tips when taking warfarin. 
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Tip number 1- Check your diet 
Remember when we talked earlier about how warfarin works, by blocking vitamin K to stop 
blood clots from forming?  Well, many foods have high levels of vitamin K in them, so, along 
with all the other monitoring, you also need to pay attention to what you eat.  Green leafy 
vegetables such as kale, spinach, and cabbage, along with broccoli, cauliflower, brussel sprouts 
and green tea are all high in vitamin K. Having large amounts of vitamin K-filled foods will 
affect how the warfarin is working in your body. If you normally have some of these foods in 
your diet, it is alright to go ahead and continue to do so.  But, be aware if you do not eat these 
types of foods on a regular basis, do not eat a large serving.  If you want to start eating more of 
these foods, talk to your doctor about how to do so. It is important to try to have a balanced diet 
and be sure to talk about food intake with your health care provider. 
 
Tip number 2: 
Please be cautious and limit or avoid the use of alcohol while taking warfarin. Drinking alcohol 
while taking warfarin significantly increases your risk for stomach bleeding and can also change 
how warfarin affects your bleeding time. 
 
Tip number 3 
Our final tip is to please use extra caution while performing activities with sharp objects that may 
lead to bleeding, such as shaving and nail trimming.  Use an electric razor when shaving and be 
sure you use a soft toothbrush when brushing your teeth. If you fall or injure yourself, check in 
with your doctor immediately to make sure you do not have any internal bleeding.   
This concludes our podcast on Warfarin. Thanks for listening to AudibleRx, here to provide you 
with simple, reliable information about your medication that you can listen to on demand. If you 
have any questions, please contact your pharmacist or doctor. Remember, this recording is not 
meant to replace your counseling session with your own pharmacist.  We hope to help educate 
you about your medication so you can confidently mange your medication.  
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2.6 Demographic Characteristic Questionnaire  
 
Sex                                               Education 
Male       ☐                                   Less than grade 8     ☐ 
Female    ☐                                 Grade 9-11                ☐ 
                                                    High school               ☐ 
Age                                             College or higher       ☐ 
18-24   ☐               
25-34  ☐                                     Ethnicity   
35-44  ☐                             Caucasian             ☐ 
45-54  ☐       Black                    ☐ 
55-64  ☐       Asian                    ☐ 
65+     ☐                               South Asian          ☐ 
  Aboriginal             ☐ 
Income                                      Other :         ☐  _____________________ 
Less than $10,000     ☐       
$10,000-$14,999       ☐ 
$15,000-$24,999       ☐ 
$25,000-$34,000       ☐ 
$35,000-$49,000       ☐ 
$50,000 +                  ☐ 
 
 
How often do you have someone help you read material about your medication? 
1☐  2☐  3☐   4☐  5☐ 
Rarely ------------------ > Always 
 
How confident are you filling out medical forms by yourself? 
1☐  2☐  3☐   4☐  5☐ 
Confident--------------> Not confident  
 
How often do you have problems learning about your medication because of difficulties 
understanding written information?  
1☐  2☐  3☐   4☐  5☐ 
Confident--------------> Not confident  
 
 
 
 
 
 
 
 
